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SUMMARY

Integration of Rous sarcoma virus DNA into its host genome
was analyzed under conditions where secondary integration via
virus spread was inhibited. This was accomplished by using the
noninfectious pol ,env alpha variant of the Bryan high titer
strain of Rous sarcoma virus (BH-RSV). Twelve independent BHRSV-transformed chicken embryo fibroblast clones were obtained
and the provirus-cell junction fragments were mapped by restriction endonuclease cleavage and Southern blotting analyses.
We found that expression of the viral genes could occur after
proviral integration at many sites on the chicken genome and
that there was no apparent preference for specific integration
sites.
BH-RSV DNA was further analyzed in order to precisely
determine the defects in this strain. A 5 kb EcoRI fragment
which contained the entire pol and src genes was molecularly
cloned from integrated proviruses of BH-RSV alpha and its pol
parent BH-RSV beta.
DNA sequencing of the pol-src junction of BH-RSV revealed
that the env sequence was almost entirely absent; only 6 bp
following the pol stop codon remained. Starting at position 7
(relative to the end of pol), a 91 bp sequence identical to the
91 bp immediately upstream from src in other strains of Rous
sarcoma virus (RSV) was found. This was followed by the src
coding sequence. It appears remarkable that in all RSV
strains, including this defective BH-RSV, as well as in

vii

cellular-src DNA, these 91 bp are conserved.
The helper virus-related sequence of about 100 bp, which
is present as a direct repeat in the 5' and 3' sides of src in
other RSVs, was present only on the 3' side of src in BH-RSV.
The sequence of about 100 nucleotides immediately following src
in BH-, PR-, and SR-RSV seems to be completely unconserved.
Restriction enzyme mapping analysis showed the structure
of the BH-RSV alpha pol gene to be basically unchanged from
that of BH-RSV beta. Using cloned DNAs, we have constructeds
molecular clones in which the pol gene of non-defective RSV was
replaced with the pol gene of BH-RSV alpha or BH-RSV beta. The
BH-RSV alpha pol gene was found to be biologically inactive in
a transfection assay. Further in vitro recombination localized
the lesion to an 859 bp Xbal-Bglll fragment in the second third
of the pol gene.
Analysis of the proteins synthesized in BH-RSV alphainfected cells revealed the fact that BH-RSV alpha directed the
synthesis of a full-sized Prl80 gag-pol precursor, yet no polymerase related proteins were found in BH-RSV alpha virion
particles. The pol lesion in the BH-RSV alpha genome appears
to cause a defect in the processing or packaging of reverse
transcriptase.
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A Note on Nomenclature: This thesis presents studies on two
isolates of BH-RSV: BH-RSV alpha (genotype gag ,pol ,env ,src )
and BH-RSV beta (genotype gag ,pol ,env ,src ). In the text,
the term "BH-RSV" was used in a general sense to refer to both
BH-RSV alpha and beta. The terms "BH-RSV alpha" and "BH-RSV
beta" were used to refer to a specific isolate.
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INTRODUCTION

Classification.

Avian RNA tumor viruses are classified in the

family Retrovirdae, subfamily Oncovirinae [91]. Retroviridae,
or retroviruses, are positive strand RNA viruses which contain
an RNA-dependent DNA polymerase (reverse transcriptase, E.C.
2.7.7.7) and replicate via a DNA intermediate. Avian RNA tumor
viruses (also known as avian sarcoma and leukemia viruses) can
be further classified into two groups, slowly transforming
viruses and rapidly transforming viruses, on the basis of both
pathology and genetics.
Slowly transforming viruses are replication competent
viruses that may cause neoplastic disease in vivo after a relatively long latent period and generally do not affect the morphology of cells in tissue culture. These viruses do not contain genes other than those needed for replication. Rapidly
transforming viruses are usually defective for replication but
cause rapid neoplastic disease in vivo and morphological
transformation of cells in tissue culture. Rapidly transforming viruses contain a specific gene which is responsible for
their oncogenic and transforming abilities. The tranforming
genes, generically known as one genes, are highly related to
normal cellular genes (c-onc genes). Rapidly transforming
viruses are believed to have arisen via recombination events
between slowly transforming viruses and c-onc genes.
Virus Particle. Retroviruses possess an enveloped particle
which is released from host cells by the process of budding.
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The physical particle (virion) of avian retroviruses consists
of: i) an internal core of viral structural proteins, pl9, plO,
p27, pl2, and pl5, ii) an outer membrane derived from the host
plasma membrane, and iii) viral surface glycoproteins embedded
within the outer membrane, gp85 and gp37. Two chemically and
genetically identical subunits of RNA and 10-20 molecules of
reverse transcriptase are packaged within the viral core. Each
RNA subunit is a complete viral genome, 8-10 kb (34-39S sedimentation value) in non-defective viruses. The RNA is single
stranded, capped at its 5' end, and polyadenylated on its 3'
end. The two genomic RNA molecules are hydrogen bonded at or
near their 5' ends, forming a 60-70S viral RNA complex. Also
within the core, is a selected population of cellular tRNAs and
trp

low molecular weight ribosomal RNAs, including tRNA
primer for negative strand viral DNA synthesis.

c

, the

Life Cycle. Virus can be adsorbed non-specifically to the
host's cell surface; however, penetration requires a specific
interaction between the viral glycoprotein and receptors on the
host cell membrane. Penetration will not occur if the virus
lacks surface glycoproteins or if the cells lack the proper receptors. Once inside the cell, the virus uncoats by an unknown
mechanism and viral RNA is reverse transcribed in the cytoplasm. Double stranded viral DNA is transported to the nucleus
and integrates into the host cell DNA. Integrated viral DNA
(provirus) then behaves like a stable Mendelian gene.
The provirus serves as the template for viral RNA synthesis. Transcription of viral RNA is controlled by a viral
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promoter mapped to the U~ region [66,152], which is located on
the 5' end of the provirus (see below). Host nucleic acid and
protein synthesis are not turned off as a result of the activity of the virus; the provirus is essentialy a subset of the
host's actively transcribed genes. Viral mRNAs consist of both
genomic-sized RNA and sub-genomic sized RNA species, the latter
generated by splicing.
Viral proteins are assembled at the cell membrane. Virion
cores containing reverse transcriptase and viral RNA (indistinguishable from genomic-sized mRNA) bud through the cell membrane into the extracellular medium. The host cell is usually
not killed as a result of viral infection, and once infected,
the cell continues to release viral particles throughout its
lifespan. Viral genetic information is thus transmitted both
by infection of new cells (horizontal transmission) and by cell
division of infected cells (vertical transmission).
Reverse Transcription and Integration. Viral DNA differs from
its RNA template in that it contains a long terminal repeated
sequence (LTR) at both ends. LTRs are composed of sequences
which derive from 1) the 3' end of viral RNA (U3), 2) from a
short direct repeat found at both ends of viral RNA (R), and 3)
from the 5' end of viral RNA (UJ. The order of these sequences is U--R-Ur and, in the avian system, the approximate
size of these regions is 250, 20, and 80 bp respectively. Generation of a terminal repeat derived from both ends of viral
RNA implies that the process of reverse transcription is more
complex than merely copying a viral template.
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Reverse transcriptase requires a primer to initiate DNA
synthesis. In avian retroviruses this is supplied as a
molecule of tRNA

p

which is base-paired at its 3' terminus to

a stretch of viral RNA (16 bp) located immediately following
Ur. Synthesis of DNA complementary to viral RNA (minus strand
DNA) utilizes the 3' OH of the tRNA as a primer and proceeds in
a 5' to 3' direction (i.e., opposite direction with respect to
viral RNA) for 101 bp ("minus strong stop DNA"), until the 5'
terminus of viral RNA is reached. The nascent DNA transcript
then "jumps" and hybridizes to an R sequence on the 3' end of
another viral RNA molecule. Synthesis of minus strand DNA continues in a continuous fashion up to the primer binding site.
The minus strand DNA is thus a complementary copy of VIRAL
GEN0ME-U3-R-U5.
The primer for plus strand synthesis has not been identified, but is presumed to bind to a highly conserved polypurine
tract (PPT) which immediately precedes U~. Plus strand synthesis appears to initiate before completion of the minus
strand. Initiation at the proposed primer binding site and
synthesis in the 5' to 3' direction (i.e., same direction as
viral RNA) would generate a DNA transcript of U^-R-Uj. ("plus
strong stop DNA"). Continued reverse transcription of the 3'
end of tRNA ^ would generate a region complementary to the 3'
end of minus strand DNA (5' end of genomic RNA) and would facilitate a second jump to a new template molecule or circularization of the growing minus and plus strands. The minus strand
acquires its second U--R-U,- by transcription of "plus strong
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stop DNA".

The plus strand acquires VIRAL GEN0ME-U 3 -R-U 5 by

transcription of minus strand DNA. The final product is double
stranded DNA with two copies of U3~R-U5 (the LTR).
This model has been proposed by Gilboa et al. [37]; similar models have been proposed by others [28,67]. Experimental
evidence in support of the model was obtained by exploiting the
ability of actinomycin D to specifically inhibit DNA-dependent
DNA synthesis, thus enabling investigators to distinguish
between plus and minus DNA transcripts. The existence of minus
"strong stop DNA" has been well documented; recently "plus
strong stop DNA" has been identified as a reverse transcription
intermediate in many retrovirus systems [10,28,79,93]. Reverse
transcription of the 3' end of the tRNA primer by the nascent
plus strand has been shown in some avian and murine rertoviruses [37,132,137]. There is still some uncertainty as to
whether the plus strand is synthesized as one continuous strand
[37] or whether a strand displacement mechanism is involved
[67].
Integration is highly specific with respect to the viral
genome. The structure of the provirus is CELL DNA-U_-R-UeVIRAL GENOME-U3-R-U5-CELL DNA. However, integration apparently
occurs randomly with respect to the host genome (see chapter
1). The process of integration causes a 4-6 bp duplication of
host sequences at the site of integration
[27,56,63,86,121,124], a property retroviruses share with
prokaryotic and eukaryotic transposable elements.
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Figure 1^. Genetic structure and protein products of nondefective avian retroviruses. The structure shown is that of
an RSV provirus; except for the src gene, the remainder of the
genome is the same in ALV. The primary translation products of
viral mRNAs and their mature cleavage products are shown
beneath the DNA sequences which code for them. Recently, a
fifth gag protein, plO, has been mapped to the region between
pl9 and p27 [103].
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Slowly Transforming Viruses:
Genetic Structure. The prototype slowly transforming
viruses are the avian and murine leukosis viruses (ALV and
MuLV). ALVs include Rous associated viruses (RAV) and related
viruses. RAV-1 and RAV-2, commonly used laboratory strains,
were originally isolated as replication competent "helper"
viruses in defective Rous sarcoma virus (RSV) stocks [41,109].
These viruses contain 3 genes whose products are both necessary
and sufficient for viral replication: gag, pol, and env (Fig.
1).
The gene order, gag-pol-env seems to be invariant. The
LTR (U3-R-U,-) is present on both ends of the proviruses. In
addition to the three coding regions, there are non-coding sequences upstream from gag and downstream from env.
Studies of the DNA of normal uninfected chickens demonstrated the existence of at least 16 genetic loci (numbered
ev-1 to ev-16) containing endogenous viral sequences, structurally related to ALV. Most chickens of the White Leghorn breed
(which is commonly used in laboratory studies) seem to contain
at least the ev-1 locus; usually one to three additional ev's
are also present. Most ev's have multiple defects and are thus
unexpressed; some ev's express part of gag ("gs " phenotype)
and/or env ( "chf " phenotype) [53].
Transcription and Translation: The gag gene codes for the
viral structural proteins, pl9, plO, p27, pl2, and pl5.
Genomic-sized mRNA is translated into a 76 kD gag polyprotein
precursor product (Pr76^ "), which undergoes proteolytic
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cleavage to generate the five viral proteins.

Processing oc-

curs in the infected cells and pulse-chase experiments have
demonstrated a presursor-product relationship between Pr76 and
the mature gag proteins [51,100].
The pol gene codes for reverse transcriptase. In the avian system the active enzyme is a dimer consisting of one
molecule of an alpha subunit, p63p , and one molecule of a
beta subunit, p95po . p95 occupies most, if not all, of the
pol coding sequences [117], and p63 is an amino terminal
cleavage product of p95 [34]. The carboxy terminal cleavage
product of p95 is a 32 kD phosphoprotein (pp32, or p32) which
has DNA endonuclease activity [115]. The exact role of the p32
endonuclease in replication has not been determined.
The identity of the mRNA species used for translation of
pol remains an enigma. The primary translation product of pol
is a 180 kD polyprotein precursor shown to have gag and pol antigenic determinants and to contain the tryptic peptides of
Pr76gag and p95po1 [100,105]. Prl80, however, is not a precursor to Pr76 since radioactivity from Prl80 does not "chase"
into Pr76 and since there is 20-50 times more Pr76 than Prl80
in cells even at early time points [100]. Prl80 was therefore
considered to be a read-through protein resulting from occasional suppression of the gag termination codon used in synthesis of Pr76. However, in vitro translation in the presence
of tRNA amber suppressor molecules yielded an 80 kD protein at
the expense of Pr76 and did not result in an increase in Prl80
[147]. Recent DNA sequencing revealed the surprising fact that
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gag and pol were encoded on different reading frames on viral
DNA. The most plausable explanation for the synthesis of Prl80
requires that a splicing event removes the gag termination codon and 10 to 20 bp in the vicinity of the gag-pol juncton,
resulting in a shift to the -1 reading frame while avoiding
creation of new in-frame termination codons. The presence of a
spliced pol mRNA has yet to be demonstrated. If such a
molecule exists, a percentage of virion particles may contain
this RNA instead of genomic RNA since in vitro translation of
virion RNA resulted in the synthesis of Prl80 and Pr76 in practically the same ratio as found in infected cells [147].
The precursor-product relationship between Prl80 and
p95/p63 has been inferred from pulse-chase experiments in which
the kinetics of disappearance of Prl80 from infected cells
correlates extremely well with the kinetics of appearance of
p95 and p63 in virion particles [100]. Since p95 and p63 do
not appear in immunoprecipitates of infected cells and since
Prl80 has not been convincingly shown to be present in virion
particles, it was not possible to demonstrate a direct relationship. Preliminary evidence presented in this thesis indicates that it may be possible to demonstrate a direct
precursor-product relationship in the virion particles.
The env gene codes for the viral glycoproteins, gp85 and
gp37. A 21S subgenomic spliced mRNA is translated into a
env
glycosylated precursor, gPr92
, the major viral glycoprotein
detected in infected cells. In the presence of inhibitors of
glycosylation, this precursor runs as a 57 kD unglycosylated
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protein.

The product of cell-free translation of 21S mRNA runs

as a 63 kD unglycosylated protein, presumably due to the presence of a signal peptide in the in vitro synthesized product.
Cleavage of gPr92 to gp85 and gp37 and formation of disulfide
linkages between the two env proteins occurs near the time of
budding, although the exact sequence of events is not clear.
gp85 confers subgroup specificity upon the virion particle. There are 6 defined viral subgroups, designated A-F,
which are encoded in different viral gp85 genes. Since host
cells may contain receptors on their surfaces for only some of
these 6 subgroups, host range is also related to gp85. Because
of variations in subgroup, the gp85 portion of env is the part
of the genome that displays the most variability among various
viral strains.
The leader sequence of the spliced env mRNA contains approximately 250 nucleotides from the 5' end of the genome. The
proposed splice donor site is located at nucleotide 18 of the
Pr76 coding sequence; the proposed splice acceptor site for env
is found within the coding sequences for an env signal peptide.
This implies that the signal peptide is composed of amino acids
which are partially derived from the leader sequence (i.e., the
first 6 amino acids). Interestingly, DNA sequencing has shown
that the coding sequences of pol and the env signal peptide
overlap by ~110 nucleotides with pol and env in different reading frames. The actual coding sequences do not overlap; env
begins 56 bp after pol terminates.
Rapidly Transforming Viruses:
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Rous Sarcoma Virus. Rapidly transforming viruses are
characterized by the presence of a specific one sequence inserted into their genomes in addition to, or instead of, the
replicative genes. The most extensively studied virus of this
class has been RSV (Figure 1).
In RSV, gag, pol and env are present and are transcribed
and translated in the same manner as described for ALV. The
size of the env mRNA of RSV is 28S, since both env and src are
transcribed; however only env is translated from this mRNA.
In addition to the ALV genes, RSV has a sequence known as
src inserted into its 3' end, between env and the LTR. Oncogenicity and transformation in tissue culture can be directly
attributed src since 1) ALV and RSV, which have quite different
pathologies, are essentially identical except for this sequence, and 2) spontaneously-derived deletion mutants in src
are invariably transformation defective (td) and have lost the
ability to cause rapidly appearing tumors in vivo [70]. The
isolation of mutants which were temperature sensitive for
transformation [72,89] suggested that the src gene product was
a protein. Finally, Erikson et al identified a 60K product of
the src gene which had an associated protein kinase activity
[35,36].
Unlike the other viral proteins, src is not a cleavage
product of a larger protein precursor. p60 is the primary
translation product of a separate spliced subgenomic mRNA of
21S.
Other Rapidly Transforming Viruses. Based on the genetic
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structure of RSV, the prototype transforming virus was considered to be composed of gag-pol-env-one; transforming viruses
which were replication defective (i.e., lacked gag, pol and/or
env information) were considered to be exceptions to this rule.
The first defective transforming virus to be described was
the env-defective Bryan high titer strain of RSV (BH-RSV) [45].
It has subsequently become clear that, except for certain
strains of RSV, all rapidly transforming viruses are defective
in replication. One or more replicative genes are replaced by
a new sequence containing the one gene. Cells containing such
viral genomes are transformed but do not release infectious
viral particles ("non-producer" cells). Figure 2 compares the
structures of some rapidly transforming viruses with that of
ALV.
The structures of the defective viruses range from replacement of one gene (BH-RSV and AMV) to replacement of all
replicative genes (Ha-MSV). In viruses in which the one gene
is inserted into gag, the transforming gene product is expressed as a gag-one fusion protein which is synthesized from a
genome-size mRNA. Products of transfoming genes in more distal
positions (such as AMV myb and AEV erbB) are thought to be synthesized off subgenomic spliced mRNA transcripts. The src gene
product of BH-RSV is known to be synthesized off a 21S mRNA
similar to non-defective RSV.
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In order to replicate, defective transforming viruses require that the missing viral products be supplied by a replication competent helper virus (such as ALV). The resulting
virion particle is called a pseudotype; the physical particle
is derived partly or wholly from the helper virus and the RNA
genome is from the defective virus.
Origin of the one Sequences. Stehlin et al. discovered that
cDNA specific for src hybridized to cellular DNA of normal
uninfected chickens with kinetics which indicated that one to
two copies of a cellular src (c-src) gene were present [130].
Hanafusa et al. found that upon injection of partial td mutants
of RSV into chicks, tumors arose after a long latent period
from which a non-defective RSV could be recovered [43]. Studies of the RNAse T, oligonucleotide fingerprints [146] as well
as tryptic peptide analyses [68] revealed that the src genes of
these recovered avian sarcoma viruses (rASV) were the products
of recombination between the residual src of the partial td mutant and the c-src gene.
Subsequently, at least 13 more unique sequences, all of
which have cellular homologs, have been identified as the
transforming genes in different rapidly transforming retroviruses. These findings led to the, now generally accepted,
hypothesis that transforming retroviruses arose by recombination events between helper viruses and c-onc genes. The level
of expression and/or the structure of the c-onc genes seem to
have been altered as a result of this recombination, endowing
these normal genes with potent transforming abilities.
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Early History of RSV; Origin of the Common Laboratory Strains.
In 1911 Peyton Rous of the Rockefeller Institute reported the
isolation of a filterable agent which produced sarcomas in
chickens [107]. The filtrate originated from a spontaneous tumor in a Plymouth Rock hen; it was designated "Chicken tumor
#1" by Rous, and later became known as Rous sarcoma virus. The
tumor had been passaged for a few years by transplantation in
blood relatives of the original chicken before it acquired the
ability to grow in all breeds of chickens. After the discovery
of the "filterable agent", virus was routinely passaged by inoculation into chickens and recovery from the resulting tumors.
The virus was passaged by Rous and his collaborators in
New York and samples were given to researchers at other institutions. However, the passage history of the virus was not
well documented. RSV strains available today are all considered to be derived from the original RSV, but precise data
on the evolution of each strain is not available. Until the
1960s, when tissue culture methods became popular, RSV was propagated by in vivo passage. Since it is now known that in vivo
passage can lead to the generation of novel recombinants
[1,43,49], the relationship between the modern RSV strains and
the original isolate is not clear. Unfortunately, there are no
remaining samples of the tumor material isolated by Rous.
Most research in the past twenty years has been performed
on a few strains, named after researchers involved in their
propagation. 1) The Schmidt-Ruppin strain of RSV (SR-RSV) was
used extensively by K.H. Schmidt-Ruppin of Germany in the

-16-

1950s.

His material originated from Rous' tumor; however it

was passaged in two other laboratories before he received it in
1953 [95]. 2) The Prague strain of RSV (PR-RSV) was used by J.
Svoboda of the Institute of Biology in Prague in the late
1950s. The genealogy of this strain is not clear. 3) The
Bryan high titer strain of RSV (BH-RSV) was developed by W.R.
Bryan of the National Cancer Institute in 1959 as a result of
over 50 successive passages of virus in New Hampshire Red
chickens. At each passage Bryan selected for the most rapidly
growing tumor to use as material for the next round of inoculation [14]. Bryan originally received RSV in 1941 from A.
Claude of the Rockefeller Institute; Claude received it from J.
Murphy, a collaborator of Rous [95]. 4) The Bratislavia 77
strain (B77) of avian sarcoma virus was isolated as a spontaneous field isolate [141]. The original B77 stock may have been
lost to contamination or mislabeling, since the present day
"B77" is indistinguishable from PR-RSV.
The Bryan Strain of Rous Sarcoma Virus. Hanafusa et al. showed
that BH-RSV was defective in the production of infectious virus
and required a helper virus for replication [41,45]. The defect could also be overcome by passaging the virus in cells of
certain chicken embryos. These embryos produced a "chicken
helper factor" (chf) which rendered the BH-RSV virions infectious for one round of replication on quail but not chicken
cells. (It was later shown that chf was subgroup E viral
glycoprotein; quail cells have receptors for this subgroup,
whereas chicken cells generally do not).
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Biochemical studies showed that BH-RSV virions lacked the
viral glycoproteins, gp85 and gp37 [114]. Oligonucleotide mapping detected the presence of a large deletion in BH-RSV as
compared to non-defective RSV [30]; the position of this deletion thus defined the location of env on the genetic map. BHRSV was used extensively as the prototype env mutant to elucidate the function of the env gene products, to identify the env
mRNA species, and to use as a negative selection for the
preparation of env-specific DNA probes. However, the precise
extent of the env deletion had not been determined and it was
not known whether any residual env information was present in
BH-RSV.
Hanafusa et al observed that 5-10% of viral particles in
BH-RSV stocks could not be complemented by passaging through
chf cells [46]. These particles, termed BH-RSV alpha, were
found to have an additional defect: reverse transcriptase activity could not be detected in these virions [44,47,101,148],
The pol defect was extremely stable; reversion of the pol
phenotype to pol was not observed. However, upon superinfection of BH-RSV alpha-infected cells with helper virus, recombination occurred, resulting in the formation of the parental
pol"*" BH-RSV (BH-RSV beta) . BH-RSV alpha is also capable of
recombining with a pol mutant, tsLA337, to yield pol BH-RSV
beta, but incapable of recombining with another pol mutant,
tsNY21 [111]. This would suggest that the defect, most likely
a deletion, maps to a particular region of pol. RNA sizing
studies failed to detect a difference between BH-RSV alpha and
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the parental, BH-RSV beta [L-H Wang, personal communication].
The nature of this defect and the mechanism for its generation
remained a puzzle.
Since BH-RSV alpha virion particles contain viral RNA,
selection of genomic RNAs for packaging into virions does not
seem to require functional reverse transcriptase. However,
BH-RSV alpha virions (as well as those of another pol mutant)
do not contain significant amounts of tRNA ^ and the other
small RNAs found avian retrovirus particles [104,113], thus implicating the reverse transcriptase protein in selection of
tRNAs for packaging.
Scope of This Thesis: Because of their specific nonconditional defects, the BH-RSV strains have traditionally been
excellent model systems for studying many viral functions. In
this thesis I present results of experiments using BH-RSV alpha
to study the specificity of RSV integration into its host's
DNA. Spread of infectious virus and concomitant multiple integration events occurred when non-defective RSV was used; this
prevented examination of specific proviruses and the adjacent
cellular DNA. With BH-RSV alpha as the exogenous virus, bands
representing the single integrated provirus were readily
detected and the lack of specific integration sites was clearly
determined.
I examined the structure and properties of the BH-RSV alpha and beta mutants in an attempt to fully characterize their
defects. A DNA fragment containing the region flanking the env
deletion in BH-RSV was sequenced, the nature of the pol protein
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products encoded by BH-RSV alpha was determined, and the BH-RSV
alpha defect was localized to a specific region of the pol
gene. Based on sequence comparisons between BH-RSV and other
retroviruses, I also obtained suggestive evidence for the importance of specific non-coding regions flanking the src gene
of RSVs.
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MATERIALS AND METHODS

Cells and Viruses:
A clone of 3Y-1 rat cells infected with BH-RSV was obtained from S. Kawai and grown in MEM media as described [69].
A stock of a RAV-1 pseudotype of BH-RSV alpha virus, [BH-RSV
alpha (RAV-1)], was generously provided by T. Hanafusa. All
preparations of BH-RSV alpha (RAV-1) are known to contain a
small percentage of the pol BH-RSV beta (RAV-1) which is considered to be a consequence of recombination events which occurred after superinfection with helper virus [46]. BH-RSV
alpha-transformed chicken cells were grown in Scherer's or
Hams' F-10 medium as previously described [42]. CEF were from
gs , chf SPAFAS embryos.
Viral Assays:
The presence of infectious transforming virus was assayed
by ability to form infectious centers on uninfected CEF in a
standard hard agar focus assay [140]. Viral reverse transcriptase activity on an exogenous template (poly rC:oligo dG) was
measured under standard conditions [145].
Cloning BH-RSV Infected "Non-Producer" Chicken Cells:
Clonal populations of chicken cells harboring BH-RSV proviruses were obtained by infecting CEF with BH-RSV alpha (RAV1) at high virus dilutions (m.o.i. 10 -10 focus forming
units/cell). Within 24 hours post-infection cells were overlaid with agar medium containing antibody that neutralized
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RAV-1.

Individual foci picked on day 8 were cultured separate-

ly, and were continuously monitored for morphology, infectivity, and virion polymerase activity. Clones of cells that were
morphologically transformed, but did not produce infectious
virus as assayed by focus formation, were further monitored for
the production of virus particles by sucrose gradient banding
35
of [ S]-methionine labeled particles from labeled cultures
[106]. Transformed clones producing noninfectious virions were
designated as BH-RSV clones. Those BH-RSV clones which, in addition, released polymerase-negative particles were designated
BH-RSV alpha clones; the clones in which sedimentable polymerase activity was detected were designated BH-RSV beta clones.
[BH-RSV beta clones have also been referred to in previous studies as BH-RSV(-)].
DNA Extraction:
g
DNA was extracted from pellets of 10 cells by the procedure of R. Junghans, Roche Institute (personal communication) . The cell pack was lysed in extraction buffer containing
70% guanidine thiocyanate, 10% 2-mercaptoethanol, 0.02 M Tris
(pH 8), and 0.001 M EDTA. CsCl crystals were added to a final
concentration of 1.4 g/ml and the final volume was adjusted to
2 ml with extraction buffer. The lysate was layered on top of
a preformed CsCl step gradient: 1.8 g/ml and 1.6 g/ml CsCl
solutions in TEN buffer (0.01 M Tris (pH 7.4), 0.001 M EDTA,
and 0.01 M NaCl). DNA was banded for 72 h at 34K in a fixed
angle rotor (Beckman T40 or Ti50) and the DNA-containing fractions, identified by viscosity and/or agarose gel electro-
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phoresis with ethidium bromide staining, were dialyzed against
TEN buffer for a minimum of 5 buffer changes (at least 8 h per
buffer change). Dialyzed DNA was then used directly in restriction enzyme reactions.
Enzymes and Enzyme Reactions:
Restriction endonuclease reaction conditions were as per
manufacturer's (New England Biolabs or Bethesda Research Laboratories) directions; enzyme buffers were either as recommended by the manufacturer or as described in Davis, et al.
[25]. Usually, at least a twofold excess over the recommended
amounts of enzyme was used for digestion of chromosomal or
closed circular plasmid DNA.
Digestions of chromosomal DNA were monitored by incubation
of an aliquot (usually 5%) of the chromosomal reaction mixture
with 1 ug of lambda or Ad-2 DNA. This marker DNA was subjected
to electrophoresis on an agarose gel, stained with ethidium
bromide, and examined under UV light for completeness of digestion. Chromosomal samples were precipitated in ethanol and run
on agarose gels only after completeness of digestion was demonstrated. Digestions of phage or plasmid DNA were monitored
directly on agarose gels.
Nick translation was performed as described by Maniatis,
32
et al. [88]. The labeled nucleotide was [alpha
P]-dCTP,
(specific activity: >2000 Ci/mmole) 10 mCi/ml in aqueous solution (Amersham) and DNA polymerase I was obtained from
Q

Boehringer-Mannheim; specific activities of 10 cpm/ug DNA were
routinely obtained.
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Ligation of DNAs was performed using under conditions
recommended by the manufacturer for joining fragments with
cohesive ends. Reactions contained 1 ul (10 units) of T. DNA
ligase (New England Nuclear) in the recommended buffer (50 mM
Tris (pH 7.4), 10 mM MgCl2, 50 ug/ml BSA, 1 mM ATP, 10 mM DTT)
and were performed at 16 C for 3-12 hours. Ligation of lambda
arms to insert DNA required a high DNA concentration in the
reaction mixture (>100 ug/ml); ligation of plasmid and insert
fragments to form circular products required more dilute DNA
concentrations (10-50 ug/ml).
Removal of 5' phosphate from DNA fragments was accomplished by bacterial alkaline phosphatase (Bethesda Research
Laboratories) treatment at 68°C for 1 hr in 10-50mM Tris-HCl
(pH 8.0).
5' end-labeling of DNA fragments with T. polynucleotide
kinase was performed at 37 C for 30 min. Reaction volumes were
40 ul and contained between 0.5 and 10 pmoles of available 5'
32
ends and 40 pmoles of [gamma- P ]-ATP (Amersham, specific activity 2000-3000 Ci/mmole, 10 mCi/ml in aqueous solution) in
kinase buffer (50 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 5 mM DTT,
0.1 mM spermidine, 0.1 mM EDTA).
Gel Electrophoresis of DNA and Filter Hybridization:
For agarose gel electrophoresis, DNA samples were run on
submerged horizontal gels (20 x 25 x 0.5 cm or 8.5 x 5.5 x 0.5
cm "mini-gels") in electrophoresis buffer (E buffer) (0.04 M
Tris-acetate (pH 7.8), 0.005 M Na-acetate, and 0.001 M EDTA).
The agarose concentration was usually 0.6-0.8% and size markers
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were lambda HindIII fragments; however when small (less than 1
kb) DNA fragments were examined, agarose concentrations of
1.5-2% and size markers of pBR322 Hinfl fragments were used.
DNA was visualized by ethidium bromide (0.5 ug/ml) staining and
UV light excitation.
For sizing restriction fragments smaller than 1 kb or as a
preparative step in obtaining a labeled DNA fragment for
sequencing, electrophoresis on polyacrylamide slab gels was
performed. The concentration of polyacrylamide was 5 or 8%
(the ratio of acrylamide to bisacrylamide was usually 19:1,
although in some cases 50:1 ratios were used) in TBE buffer (50
mM Tris (PH8.3), 50 mM boric acid, 1 mM Na

EDTA) as described

by Maxam and and Gilbert [92]. For both agarose and polyacrylamide gel electrophoresis, the voltage and the time of
electrophoresis was usually determined empirically.
Southern transfer [127] of DNA from agarose gels to nitrocellulose filters (Schleicher & Schuell), hybridization to radioactive probes, and washing of filters were carried out as
previously described [10, see also Molecular Cloning section
below], except that unlabeled salmon sperm carrier DNA was added to the hybridization solution at a concentration of 250
ug/ml. Filters which were to be re-hybridized to a second radioactive probe were soaked in pre-hybridization solution (hybridization solution with H20 substituted for formamide) at
80 C for 10 min to remove the first probe.
Radioactive Probes:
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1. RAV-2

probe:

RAV-2 DNA purified from a lambda RAV-2

clone [65] was cut into two fragments with the enzymes Hindlll
and Sail. Such cleavage generates one fragment of 4.25 kb,
which contains a portion of the env gene, the LTR, and the entire gag gene, and another fragment of 3.3 kb, which contains
the entire pol gene and part of the env gene. These two fragments have been subcloned separately into pBR322 [133].
32
[ P]-RAV-2
probe was prepared by nick translation of a 1:1
mixture of these two pBR322 subclones.
32
2. pol probe: [ P]-pol probe was prepared by nick translation
of the pBR322 subclone containing the 3.3 kb Hindlll-Sall RAV-2
fragment mentioned above.
32
3. cDNA c , : [ P]-cDNAc, which consists of the first 101 nucleotides from the 5' end of RAV-2 (formerly known as "strong
stop" DNA), was generously provided by B. Neel, The Rockefeller
University. This probe was made by previously published procedures [50,53].
32
4. LTR probe: [ P]-LTR DNA which contains all the 5' and 3'
sequences present in one copy of the long terminal repeat of
SR-RSV was obtained by EcoRI digestion of a lambda SR-RSV clone
which contains two copies of the LTR [133] followed by nicktranslation of the purified 350 nucleotide'fragment.
32
5. src probe: [ P ]-src probe was made either by nick translation of a pBR322 subclone containing the 3.8 kb EcoRI srccontaining restriction fragment from the lambda SR-RSV clone
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mentioned above [133], or by nick-translation of a purified 600
bp Haelll fragment cut from the 5' region of the src gene of
the subclone.
DNA Sequencing and Analysis of Sequence Data:
The chemical cleavage method of Maxam and Gilbert [92]
with the hydroxylamine modification of Schmid and Rubin [108]
for cleavage at cytosines, was used throughout. Fragments to
be radioactively labeled were generated by cleavage with restriction enzymes which produce 5' protruding ends. The 5' ends
were radioactively labeled using T- polynucleotide kinase and
32
gamma-[ P]-ATP as described above. To obtain DNA fragments
labeled at a single end, further digestion of double endlabeled fragments with other restriction enzymes or separation
of the two DNA strands was performed; both procedures are
described by Maxam and Gilbert [92]. All regions were sequenced at least twice (on both DNA strands, when possible);
the sequences of restriction enzyme cleavage sites were confirmed by DNA sequencing.
Analysis of DNA sequences for the presence of restriction
enzyme cleavage sites, or for identification of regions of extensive homology was facilitated by use of the computer programs SEARCH and SEQFIT, respectively [128].
Bacterial Cells, Phages, and Plasmids:
Escherichia coli strain ED 8654 [96] was used for isolation and propagation of recombinant bacteriophage. The bacteriophage vector lambda gtWES lambda B [82] was used to con-
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struct recombinant bacteriophage.

This vector was digested

with Eco Rl and Sac I, and the Eco Rl arms were purified from
the dispensable lambda B fragments by sucrose density gradient
centrifugation. E. coli strain HB101 was used for transformation and amplification of plasmids [12]. The plasmid pBR322
[9] was used in the construction of recombinant plasmid DNA.
The recombinant plasmid clones pSR-REP and pSR-XD were
generous gifts of F. Cross, The Rockefeller University. The
construction of these plasmids from pSRA [26] has been
described [24].
Molecular Cloning of Fragments from BH-RSV Proviral DNA:
550 micrograms of pooled DNA from BH-RSV alpha chicken
cell clones and 350 micrograms of DNA from BH-RSV beta rat 3Y-1
cells were completely digested with EcoRI. Digested DNA was
fractionated on a sucrose gradient, and fractions containing
the 5 kb viral pol-src fragment were identified by subjecting
an aliquot of each fraction to agarose gel electrophoresis and
subsequent hybridization of the Southern blot to src-specific
probe. For both BH-RSV alpha- and BH-RSV beta-containing DNA,
the hybridizing band was present in three consecutive fractions; DNA from the fraction with the strongest hybridization
was concentrated by precipitation in ethanol. The yield was
approximately 30 and 10 micrograms of 5 kb insert from BH-RSV
alpha and BH-RSV beta, respectively. 0.075 micrograms of insert DNA was ligated to 1 microgram of EcoRI arms of the phage
vector, lambda gt WES, (2:1 molar ratio of arms:insert) and
packaged in an in vitro lambda packaging system [57].
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Details of procedures for in vitro packaging [5,57],
screening [6], phage purification, amplification and preparation of phage DNA have been previously described [65]. The efficiencies of packaging of recombinant bacteriophage ranged
5 6
from 10 to 10 infectious particles/ug phage DNA. Recombinant
bacteriophage were plated on 20 x 20 cm "bioassay" plates
(Nunc) (200,000-400,000/plate) and screened. Before hybridization, filters containing phage DNA imprints were prewashed at
37° in pre-hybridization buffer (5 X SSC (1 X SSC is 0.15 M
NaCl, 0.015 M Na citrate), 0.02 M Tris-HCl (pH 7.4), and 0.5%
SDS) for at least 45 min. Hybridization was was carried out at
37 in hybridization buffer (50% formamide, 5 X SSC, 20 mM
Tris-HCl (pH 7.4), 0.5% SDS), and at least 200 ug/ml salmon
sperm DNA for 18-24 hr. Ten ml of hybrid mix containing 2 x
10 Cerenkov cpm of probe were used for each filter. Following
hybridization, filters were washed 3 times briefly in 0.2 X
SSC/0.2% SDS and then incubated once or twice for 45 min each
at 37 in the same solution. Positive plaques were purified
three times before amplification.
Purification of DNA Fragments:
DNA fragments visualized by ethidium bromide staining of
agarose or polyacrylamide gels were purified as a result of being cut out from the gel and electroeluted in dialysis tubing
containing E buffer.
Subcloning in Plasmid Vectors:
The 5 kb EcoRI fragment from BH-RSV alpha and BH-RSV beta
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was purified from the respective lambda clones and subcloned
into pBR322 according to standard procedures: phosphatase
treated EcoRI-cut pBR322 was ligated to equimolar amounts of 5
kb insert DNA and the ligated products were used to transform
E. Coli HB101. For in vitro recombination reactions, insert
and vector fragments (described in the text) were ligated and
the ligation products were used to transform HB101.
Transformation of E. Coli was accomplished by addition of
ligated plasmid DNA to CaCl2-treated bacterial cells [87];
transformants were identified by their ability to form colonies
on agar media containing tetracycline (EcoRI inserts) or amplicillin (EcoRI or Sail inserts). For initial screening of
clones, plasmid DNA of antibiotic-resistant colonies was isolated from 1-5 ml bacterial cultures by the rapid alkaline
lysis technique [8].
Transfection of CEF with Viral DNA:
Preparation of CEF and transfection of SR-RSV cloned DNA
were performed as described [24]. Secondary CEF were seeded
5
16-24 hr prior to transfection at a density of 7 x 10 cells/60
mm culture dish. For the transfection period only, the culture
medium was replaced with F10 medium lacking Tryptose Phosphate
broth. Equal quantities (between 0.1 and 1 ug) of pSR-REP DNA
(or pSR-REP-derived recombinants) and pSR-XD DNAs were cut with
Sail, ligated briefly (30 min at 16 C, in standard ligation
buffer with 2 units of T. ligase in 50 ul, at a DNA concentration of approximately 200 ug/ml) and transfected onto CEF. The
DNA-calcium phosphate coprecipitate remained on the cells for 6
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hr; at 6 hrs and again at 18 hrs, the culture supernatants were
replaced with fresh F10 medium. Cells were passaged on the
third day post-transfection, overlaid with F10 soft agar medium
24 hrs later, and monitored for the appearance of characteristic foci. For determination of the titer of infectious viral
particles in culture supernatants, agar overlay was omitted.
Isotopic Labeling of Cells and Preparation of Cell Extracts:
Unless otherwise indicated, cells grown in 65-mm tissue
culture plates were incubated for 4 hr in 1 ml of methioninefree minimal essential medium (GIBCO) containing 100 uCi of L35
S-methionine (1200 Ci/mmole, Amersham or New England Nuclear) . The cultures were washed twice in cold Tris-Glu buffer
(25 mM Tris pH 7.4; 135 mM NaCl; 5 mM KC1; 0.4 mM Na2P04; 5.5
mM glucose), and lysed in 400 ul in slightly modified RIPA
buffer [13], (0.05 M Tris-HCl, pH 7.4; 0.15 M NaCl; 1% Trition
X-100; 1% sodium deoxycholate; 0.1% SDS; 1 mM EDTA) containing
1% Trasylol (a general serine protease inhibitor, FBA Pharmaceutical, New York). Lysed cells were scraped from the plate
with a rubber policeman and transferred to a 1.5 ml Eppendorf
micro test tube (Brinkman). After vigorous vortex mixing for
30 sec, the sample was centrifuged in a precooled Beckman Microfuge B for 4 min. The resulting clarified supernatant was
used in all subsequent manipulations (100 ul per immunoprecipitation).
Isotopic Labeling of Virus and Preparation of Virion Extracts:
For continuous labels, transformed cells grown in 65-mm
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tissue culture plates were incubated in 1 ml of methionine-free
minimal essential medium (GIBCO) containing 100 uCi (unless
35
otherwise indicated) of L-[ S]-methionine sfor two successive
12 hr labeling periods followed by a 12 hr incubation in complete medium. Culture supernatants from the three incubations
were harvested and cell debris was removed by pelleting in a
Sorval centrifuge (8,000 rpm for 20 minutes). To obtain purified labeled virions, the clarified supernatant was layered
over 2 ml of 20% sucrose in a Beckman SW50.1 centrifuge tube.
Centrifugation at 45,000 rpm for 45 minutes resulted in precipitation of virion particles. The virus pellet was resupended in
100 ul of RIPA buffer containing Trasylol (1%) and used in immunoprecipitation experiments.
For pulse-chase experiments, the labeling times and
amounts of isotope used are described in the figure legend.
Unless otherwise indicated, purification of the labeled virions
was performed as described above.
Immunoprecipitation:
Rabbit antiserum raised against total virion proteins
(anti-virion serum) was a generous gift from Ricardo Feldman,
The Rockefeller University; antiserum raised against avian
myeloblastosis virus reverse transcriptase (anti-pol serum) was
obtained from the Office of Program Resources and Logistics of
the National Cancer Institute. Preabsorbed serum was prepared
by adding 10-20 ug of protein from disrupted purified RAV-2 in
modified RIPA for each 1 ul of anti-pol serum, incubating at
4 C for 60 min, and spinning out the precipitate in a Beckman
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Microfuge.

Aliquots of cell extracts were incubated with 5 ul

of unabsorbed serum or 10 ul of absorbed serum for 60 min on
ice. Three serum volumes of Staphylococcus aureus protein ASepharose CL 4B (Sigma) (a 50% vol/vol slurry in modified RIPA
buffer) was added and mixed for 30 min at 4 C to adsorb immune
complexes by the method of Kessler [75]. The Sepharose pellet
was washed five times in RIPA buffer and twice in H20. The
pellet was then suspended in 40-100 ul of gel sample buffer
(62.5 mM Tris (pH6.7), 3% SDS, 10% sucrose, 0.1 M DTT) and
boiled for 5 min. before loading on a polyacrylamide gel.
SDS-Polyacrylamide Gel Electrophoresis:.
Polyacrylamide slab gels (ratio of acrylamide to bisacrylamide was 30:0.8) containing 0.1% SDS were prepared according to the procedure of Laemmli [80]. Gels were run at 12 to
20 mA constant current, until the tracking dye reached the bottom of the gel. Gels were fixed briefly and were stained when
it was necessary to identify unlabeled molecular weight mark35
ers. To locate [ S]-methionine-labeled proteins, fixed gels
were fluorographed using Enhance (New England Nuclear) according to the manufacturer's directions. Gels were dried onto
filter paper before exposure to film.
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Chapter 1
Integration of RSV into chicken cellular DNA

INTRODUCTION
Since the integrated proviral DNA of retroviruses is a
linear non-permuted copy of the viral RNA with LTRs at both
ends [18,38,62,111], the integration event seems to be highly
specific with respect to the viral DNA. In this study, BH-RSV
alpha-infected CEF were used as a model system to determine
whether there was any specificity for proviral integration on
host DNA.
Although the techniques used in this study of proviral integration were similar to the methods used in the other studies
of this nature, attempts were made to overcome two difficulties
encountered in previous analyses of ASV-infected chicken cell
clones [61,111]: 1) the ambiguity in identification of fragments corresponding to exogenous proviruses, and 2) the lack of
clonality of the exogenous proviruses found in chicken clones
grown by conventional methods. The first problem was addressed
by including in our DNA analyses the uninfected CEF from which
the infected clones were derived. The second problem was overcome by the use of BH-RSV alpha as the exogenous provirus.
The lack of clonality of exogenous proviruses within a
colony of ASV-infected chicken cells is likely due to virus
spread and reintegration. Since the BH-RSV alpha strain is defective in the functioning of both the pol and env genes
[46,47], the virions are therefore non-infectious. A cell in-
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fected with highly diluted BH-RSV alpha should divide and grow
into a clone in which each cell contains a provirus only at the
original integration site(s). Therefore, use of this defective
RSV allows one to examine cells containing one (or few) proviruses without resorting to the use of non-permissive heterologous host cells. Analysis of such BH-RSV alpha-infected
chicken cell clones showed that, in fact, clonality of proviral
integration sites was maintained.
The results presented here demonstrate that expression of
the viral genes could occur after proviral integration at many
sites on the chicken genome and that there was no apparent
preference for specific integration sites.
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RESULTS

Restriction Map of BH-RSV
To determine which restriction enzymes would be suitable
in studying of BH-RSV alpha integrated proviruses and in
preparation for eventual molecular cloning of this virus, a
preliminary restriction map of the provirus was constructed.
For this purpose I used a clonal line of 3Y-1 rat cells which
contained integrated provirus from BH-RSV beta [69] as a source
of DNA.
EcoRI sites in BH-RSV. EcoRI cuts within the LTR of Rous
sarcoma and avian leukosis viruses [26,38,54,58,65,118,139];
therefore, this enzyme is very useful for mapping studies since
it generates the same internal proviral fragments regardless of
the cellular site of integration.
The EcoRI site in the env gene of other Rous sarcoma and
avian leukosis viruses was not present in BH-RSV. Digestion of
BH-RSV-infected 3Y-1 rat DNA with EcoRI yielded two fragments
of approximately 2.5 and 5.0 kb which hybridized to viral sequences (Fig. 1.1, lane 1). Similar digestion of SR-RSV DNA
yields three fragments of 2.5, 3.8, and 3.2 kb. Since the BHRSV 2.5 kb fragment comigrated with the 2.5 kb EcoRI fragment
from cloned SR-RSV DNA, hybridized to cDNA-,, and did not hybridize to pol probe (data not shown), this fragment appeared
to be identical to the 2.5 kb gag-containing EcoRI fragment
identified in other Rous sarcoma and avian leukosis viruses.
The ~5.0 kb fragment appeared only in EcoRI digests of BH-RSV

Figure l_.l.. BH-RSV-infected rat cellular DNA digested with
restriction enzymes and hybridized to viral probes. Samples
containing of 10 ug of total cellular DNA were digested with
the restriction endonucleases specified below, subjected to
electrophoresis on agarose gels, and transferred to nitrocellulose paper as described in the text. The blots were then hybridized to the viral probes specified below. The positions of
the lambda DNA molecular weight markers run in a parallel lane
are indicated on the left. Size values are expressed in kilobases. Lane 1, EcoRI digestion, hybridized to RAV-2
probe;
lane 2, EcoRI-HindIII double digestion, hybridization to RAV2
probe; lane 3, EcoRI-SacI double digestion, hybridization
AV
to ^ " 2 r e _ probe; lane 4, EcoRI-Kpnl double digestion, hybridization topRAV-2
probe; lane 5, EcoRI-Kpnl double digestion,
hybridization to LTR probe; lane 6, EcoRI-Kpnl double digestion, hybridization to src probe. Lanes 5 and 6 were rehybridizations of the sample in lane 4.
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DNA, whereas the two fragments of 3.8 and 3.2 kb normally
present in EcoRI digests of RSV DNA, did not appear in this
virus strain. The 5.0 kb fragment hybridized to pol and src
probes, and did not hybridize to cDNA^, (data not shown); the
size and genetic content of this new fragment is consistent
with its being a fusion of the 3.2 and 3.8 kb fragments, minus
the env sequences.
Mapping other enzyme sites in relation to EcoRI sites.
For integration studies, restriction enzymes which cleave at
only a limited number of sites within a provirus are useful.
DNA extracted from the BH-RSV 3Y-1 rat cells was digested with
HindIII, Sad, Kpnl, and Pvul, and then hybridized to RAV-2 ,
src, or LTR probes. Digestion with Hindlll, Sad, or Kpnl produced two large fragments which were detected by both RAV-2
and LTR probes (data not shown). Therefore, these fragments
were provirus-cell junction fragments. No viral fragments other than those detected with LTR probe (i.e., internal fragments) were detected with the RAV-2 or src probe. This is
rep
consistent with the hypothesis that HindIII, Sad, and Kpnl
each have only one recognition site within the BH-RSV provirus.
The DNA was digested with EcoRI followed by a second
digestion with Hindlll, Sad, or Kpnl. The fragments resulting
from the double digestions were compared to those generated by
single EcoRI digestion. The SacI site mapped within the 2.5 kb
EcoRI fragment while the Hindlll and Kpnl sites mapped within
the 5.0 kb fragment (Fig. 1.1, lanes 2-4). In the EcoRI-Kpnl
digestion, the 5.0 kb fragment was cleaved into a 2.7 kb frag-
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ment which was detected with RAV-2

probe (lane 4) and a 2.4
rep ^
kb fragment detected with LTR (lane 5) or src (lane 6) probe.
A map of these enzyme sites on the BH-RSV genome is presented
in Fig. 1.2. For the three enzymes other than EcoRI, the single recognition site in BH-RSV corresponded to a site mapped
previously at the same position on the genome of other strains
of RSV. However for Hindlll and Sad, a second site assigned
to env in many RSV strains, was missing in BH-RSV.
The enzyme Pvul cuts most RSV DNA in the U3 sequences,
generating a unit length provirus band upon hybrization to
viral probe [26,38,58,65, 118,138,139]. Although the LTR of
BH-RSV contained the EcoRI recognition sites, the Pvul sites
were absent (data not shown).
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Figure 1^.2^. Restriction map of integrated proviral BH-RSV DNA
compared with RSV DNA. The restriction enzyme cleavage sites
on the BH-RSV genome were determined by single and double
digestions, followed by hybridizations to specific viral probes
as described in the text. Restriction enzyme sites on the RSV
genome are shown for comparison. The RSV data were compiled
from previous reports [26,54]. The sizes (in kilobases) of the
EcoRI fragments of BH-RSV and RSV were determined by agarose
gel electrophoresis. The broken line and the question mark on
the BH-RSV genome represents the uncertainty regarding the
amount of env information in BH-RSV. The boxes at the ends of
the genomes represent the long terminal repeats of BH-RSV and
RSV.
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Analysis of BH-RSV alpha-Infected Chicken Cells: Integration
Sites in Clonal Cells
Twelve independent "non-producer" clones were isolated
from CEF infected with BH-RSV-alpha(RAV-1). Of the 12 clones,
11 were BH-RSV alpha type, 1 was BH-RSV beta; all 12 produced
virion particles as well as all the intracellular viral precursor and structural (but not envelope) proteins (data not
shown). DNA from the 12 clones and from the 2 uninfected embryos from which these 12 clones were derived was extracted and
analyzed.
Integrity of the BH-RSV proviruses. DNAs from the 12 BHRSV-infected CEF clones and the 2 uninfected chicken embryos
were digested with EcoRI. Structural integrity of the proviruses was ascertained by the presence of the 2.5 kb and 5.0
kb internal BH-RSV EcoRI fragments.
Figure 1.3 (panel A) shows an analysis of cellular DNA cut
with EcoRI and hybridized to RAV-2 probe. The RAV-2 probe
was used to avoid detecting the cellular src bands. The same 5
bands of 15, 11, 8.6, 8.4, and 4.2 kb (the 8.6 and 8.4 kb bands
run as a doublet) were detected in the two uninfected cell DNAs
(lanes 1 and 8). Based upon hybridization with specific probes
(data not shown), and comparison to the known EcoRI maps of the
avian endogenous proviruses [60], the bands at 15 and 8.4 kb
were identified as the proviral-cellular junction fragments of
ev-1, the 11 and 8.6 kb bands as the junction fragments of ev4, and the 4.2 kb band as the internal EcoRI fragment of both
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ev-1 and ev-4.

Thus, cells used for infection in this experi-

ment contained the non-expressed endogenous proviruses ev-1 and
ev-4 as defined by Astrin and others [2,3,53].
Clones 2-7 and 10-14 all contained the expected 2.5 and
5.0 kb internal fragments of BH-RSV. Only in clone 9 was a new
pattern detected; the 5.0 kb fragment was absent, and instead a
new band at 12 kb was detected. Since the 2.5 kb band in clone
9 was normal, the EcoRI site in the left-hand LTR and the
internal site in gag were both present. This provirus appears
to have lost the EcoRI site in the right-hand LTR and the 12 kb
band should contain the remainder of the proviral 5.0 kb fragment linked to flanking cellular sequences downstream (rightward) of the provirus.
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Number of proviruses and clonality of proviruses.

DNA

from clones 1-14 was digested with EcoRI and hybridized to
cDNA5,. cDNA5, will hybridize to the 2.5 kb internal fragment
and to a provirus-cell junction fragment at the 3* end of the
provirus. The number of new junction fragments in a sample is
indicative of the number of proviruses present. The results of
this analysis are shown in Fig. 1.3 (panel B). The bands in
lanes 1 and 8, which contained DNA from uninfected cells, were
the LTR-containing fragments of ev-1 and ev-4. The 2.5 kb
internal fragment was detected in lanes 2-7, and 9-14. One
unique junction fragment was detected in each sample for lanes
2-7, 10, and 12-14. The 12 kb junction fragment detected in
clone 9 with RAV-2 probe (Fig. 1.3, panel A) was not detected with cDNA,-,; the defect in this provirus must also affect
the 5' sequences of the right-hand LTR. No junction fragment
could be detected in clone 11, probably because the fragment
was too small. Fragments smaller than 0.6 kb would run off
this gel. Experiments with other enzymes did demonstrate the
presence of junction fragments in clone 11 (see below). The
junction fragment of clone 13 is difficult to see due to a partial "dead spot" in the nitrocellulose at that location; on
longer exposure the indicated junction band became much more
evident. To verify that the junction fragments in all the samples were truly unique, similar analyses were performed with
other enzymes.
DNA from the 14 samples was subjected to digestion with
Hindlll, Sad, and Kpnl, all of which cut BH-RSV DNA at only
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one site (Fig. 1.2). DNA was hybridized to a probe specific
for the LTR. Since the homology between the U- region of the
LTRs of exogenous and endogenous viruses is limited [16], this
probe shows preferential hybridization to exogenous proviral
sequences.
As can be seen in Fig. 1.4, the enzyme Hindlll generated a
unique set of junction fragments in each sample. Analysis with
SacI and Kpnl gave similar results (data not shown). Occasionally, only one of the two junction fragments in a sample was
detected when a particular enzyme was used (for example, in
Fig. 1.4, lanes 11 and 12). This would be expected in cases
where the second junction fragment is too large (or in the case
of SacI fragments, too small) to be resolved on the particular
gel. However, each sample which failed to reveal both junction
fragments when cleaved with one enzyme, did reveal two junction
fragments with the two other enzymes tested. Clone 9, which
was found to be missing the EcoRI site as well as most of the
5' sequences of the right-hand LTR (Fig. 1.3), apparently retained most of the 3' information in that LTR. We detected
both right and left-hand junction fragments in clone 9 when LTR
probe was used on Hindlll, SacI, and Kpnl digestions (Fig. 1.4;
data not shown). If clone 9 has a deletion it is likely that
only the last 150 bp of the right-hand LTR are missing from the
provirus. However, it is possible that the deletion extended
into the flanking cellular sequences.

Figure 1..4. Clonal Chicken cellular DNA digested with Hindlll
and hybridized to the LTR probe. The contents of the lanes,
the markings on the right, left, and bottom, and the experimental details were all as described in the legend to Fig. 1.3,
except that the restriction enzyme was Hindlll and the probe
was the LTR. The junction fragments which mapped to the right
end of the BH-RSV provirus are indicated by solid arrowheads;
the junction fragments which mapped to the left end of the BHRSV provirus are indicated by open arrowheads. The order of
the fragments was determined by rehybridization of this blot to
other viral probes (data not shown). The extra fragments in
lane 4 were products of partial digestion.
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The blots from the Hindlll, SacI, and Kpnl analyses were re-

hybridized to probes for selected parts of the RSV genome (da

not shown) so that the restriction fragments could be ordered
for construction of the maps shown in Fig. 1.5.

-47-

Kbp

• --fcoRl
• --H/ndlll
• --Kpnl
* --Sad

Ol

Cell

2 3 4 3 6 7 8

( gog )( po i ) (src K

•

Ti

Cell

t T

TT!

•

£

•

A
I

•
I

.•

12

• A •
I I I

ST

t

7•
H3^—^

Figure l^lL* Restriction maps of the cellular integration sites
of 12 independent BH-RSV-infected chicken cell clones.
Cleavage sites for the restriction enzymes were determined by
digestion of total cellular DNA and hybridization to specific
viral probes, as described in the text. The scale and genetic
map are shown at the top. The LTRs are depicted by boxes, as
described in the legend to Fig. 1.2. The numbers at the ends
of each line are the clone numbers, as described in the legend
to Fig. 1.3. The break in the cellular DNA of clone 11
represents 6 kb. A right LTR is not depicted for the provirus
in clone 9 since we determined that the provirus was missing
viral sequences in that region (see text). There may be a
deletion which spans the last 150 bp of proviral DNA; the deletion may also include an undetermined length of cellular DNA in
the region immediately flanking the provirus of clone 9. Kbp,
kilobase pairs.
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DISCUSSION

Since the discovery of the site-specific integration
mechanism of bacteriophage lambda into E. Coli [15,81], many
investigators have examined the mechanism by which other elements integrate into their host cells. It has now been established that DNA tumor viruses such as SV40 integrate randomly
with respect to their own genomes as well as the host DNA
[11,76]. In avian and mammalian retroviruses, the integration
event has been found to be extremely specific with respect to
the viral genomes [18,20,38,61,62,111,122], with the LTR probably playing an important role in this specificity.
Isolation of RSV-Infected Cells Which Contained Single Proviruses
The studies reported here re-address the question of
specificity using an avian retrovirus and its natural host
cells under conditions which select for initial integration
events. The virus employed (BH-RSV alpha) contains genetic defects in the pol and env genes. Initial infection was possible
because both of these essential proteins were obtained from a
complementing virus. Once infection was established under conditions where cells were infected by a single BH-RSV
alpha(RAV-l) particle without a helper virus, the only viral
genome present in the cells was that of the replicationdefective BH-RSV alpha. Thus, multiple infection and virus
spread were effectively prevented.
The results of Figs. 1.3B and 1.4 verified that clones of
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infected chicken cells that harbored only a single provirus
were obtained. This is in contrast to the results of others
who were unable to obtain clonal populations of ASV-infected
chicken cells by conventional methods [61,111]. Although the
conditions we employed selected for infection by a single virus
particle, the number of integration events which could be effected by a single particle was not under selective pressure.
Our results therefore confirm the notion that single particles
introduce single integration events. The appearance of multiple proviruses in a clone of infected cells, as has been reported by many investigators [7,38,61,111,129], can be primarily attributed to viral reinfection.
Expression of Viral Genes and Structure of Proviruses
The clones described were selected initially on the basis
of transformed phenotype (src) and subsequently found to be positive for production of virus particles (gag). Thus, in each
clone examined, the provirus was capable of supporting expression of the entire viral genome, regardless of the site of integration. Furthermore, as determined by restriction enzyme
mapping, the cloning procedure did not cause the appearance of
any grossly aberrant proviruses. Clone 9 was found to have a
defect in its right-hand LTR. The transformed phenotype of
clone 9 was indistinguishable from that of the other 11 clones,
as were the levels of intracellular and virion-associated viral
structural proteins (data not shown). In addition, transforming virus was successfully rescued from a plate of clone 9
cells superinfected with helper virus. It seems the defect in
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this provirus did not affect any viral functions.

Even if the

signals for termination and polyadenylation of viral RNA transcripts were affected, there is evidence to suggest that viral
RNA could be synthesized using cellular signals [151].
Lack of Common Integration Sites
Using four restriction enzymes, we found no similarities
among the cellular integration sites of the 12 independent
clones studied (Fig. 1.5). In addition there was no evidence
of more than one provirus integrating into the same site in opposite orientations. Enzymes were found which cleaved at or
very near the integration site in some but not all clones (Fig.
1.5). Thus, we conclude that the base sequence 100-500 nucleotides around the integration site differed among the clones.
However these, as other similar studies, cannot eliminate the
possibilities that 1) very short sequence similarities exist at
or near the various possible integration sites, or 2) the provirus recognizes specific cellular sequences but integrates distal to such sites. Since the clones that were studied all
survived the integration event, it was impossible to determine
the number, if any, of "forbidden" sites for integration (i.e.,
into vital cellular genes). Within the limits mentioned, we
detected no apparent preferred or specific acceptor site(s) for
ASV. This finding supports the conclusion of others:
No preferential integration has been found in mouse cells
infected with murine leukemia virus [4,129] or mouse mammary
tumor virus [18,39]. In the avian system, RAV-0 [64], avian
myeloblastosis associated virus-2 [7] and reticuloendotheliosis
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virus [74,122] were found to be non-specifically integrated
into chicken embryo fibroblasts. With Rous sarcoma virus,
similar results were obtained in infected rat [19,62], duck
[38], and quail cells [111]. This report and that of Hughes et
al. [61] examine integration into chicken cells (the natural
host).
The results presented in this report confirm and extend
the findings of Hughes et al. Under conditions which select
for initial integration events, Rous sarcoma virus integrated
into chicken DNA at no preferred sites. In addition, expression of the proviral genes was shown to be compatible with proviral integration at multiple sites.
Recently, DNA fragments containing proviruses and the
flanking host DNA have been molecularly cloned and examined.
DNA sequence analyses of proviruses of several avian and mammalian retroviruses have revealed the consistent presence of a
4-6 bp duplication of host DNA at the site of integration
[27,56,63,86,121,124]. There does not seem to be any specificity with regard to the sequence of the integration site (i.e.,
the repeated nucleotides), although the number of nucleotides
which are duplicated seems to be characteristic of the retrovirus species and may reflect the involvement of a virally encoded function (possibly pl9 or reverse transcriptase) in the
integration process.
Keshet and Temin proposed that integration can occur at
multiple sites in the genome, but biological expression of the
proviral genes can only occur via integration at a "limited"
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number of sites [74]. We found twelve expressed proviruses integrated at twelve different sites. Thus, this "limited"
number, if it exists, must be significantly larger than twelve.
Oncogenesis by avian leukosis virus involves a "promoterinsertion" mechanism [97]. Although avian leukosis virus can
express all its replicative functions via random integration,
Neel et al. found that in avian leukosis virus-induced tumors,
the proviruses were all integrated at a specific site. In
light of their results, it seems likely that viral integration
at specific sites would be found only in cases where there is
selection for expression of a function which is not encoded on
the viral genome (such as tumor formation by avian leukosis
virus). Transformation by avian sarcoma virus would not be in
this category.
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Chapter 2
Genetic structure of BH-RSV:
The pol-src junction and the src-U~ region

INTRODUCTION
Both BH-RSV alpha and beta have been used extensively in
genetic analyses of RSV. The pol and env defects have been
well characterized biologically; to complete the biochemical
characterization of the defects in the BH-RSV strains, DNA
fragments containing the defective regions were molecularly
cloned and analyzed.
In this study, I examined the sequence of the pol-src region of BH-RSV to determine whether residual env coding information was present on the BH-RSV genome. The mechanism of generation of this deletion is not known, and the regions flanking
the deletion were examined for the presence of homologous sequences which may facilitate the process of deletion.
Recent DNA sequencing of the src genes of two other
strains of RSV, SR- and PR-RSV, revealed the presence of direct
repeats and other features in the non-coding regions flanking
the 5* and 3' sides of src [117,135,136]. The sequence of the
homologous region in BH-RSV was determined in an attempt to
gain insight into the recombination events which resulted in
transduction of the c-src gene into a retrovirus.
The sequence of BH-RSV was also examined in an effort to
obtain information regarding the genesis of BH-RSV. Because of
uncertainties in the passage history of the RSV strains (see
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introductory chapter), it is not actually known whether BH-RSV
was a deletion mutant of a non-defective RSV or an independent
recombinant between a helper virus and c-src.
The results indicated that essentially the entire env and
5' flanking region of src were absent from BH-RSV. Comparisons
between BH-RSV sequences and other retrovirus sequences, revealed the presence of two regions of highly conserved noncoding sequences. The origin of BH-RSV could not be determined
since the sequence did not provide strong evidence for either
the env deletion or independent recombinant model.

-55-

RESULTS
Analysis of Molecular Clones of BH-RSV
Molecular Cloning of 5 kb pol-src fragment of BH-RSV alpha
and beta. The 5 kb EcoRI fragment of BH-RSV alpha and beta was
cloned from the infected cells which were used in the integration study (chapter 1). DNA from BH-RSV alpha chicken cell
clones 2-7 and 10-13, and DNA from BH-RSV beta rat 3Y-1 cells
were completely digested with EcoRI, fractionated on a sucrose
gradient, and DNA fractions containing the 5 kb viral pol-src
fragment were cloned into the EcoRI site of the phage vector,
lambda gt WES. For both BH-RSV alpha and BH-RSV beta, a lambda
clone containing the 5 kb EcoRI pol-src fragment was isolated
and purified. In order to increase the ratio of insert DNA to
vector DNA, the 5 kb viral fragment was subcloned into the
EcoRI site of the plasmid pBR322. Plasmid clones containing
the 5 kb fragment from either BH-RSV alpha or beta were isolated; one clone of each, refered to as pBH-alpha or pBH-beta, was
chosen for further analysis. The structure of these plasmid
clones is shown in Figure 2.1.
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Figure 2^1^ Structure of BH-RSV molecular clones. The upper
portion of the circles represent the 5 kb EcoRI viral insert
fragments. The lower portion represents pBR322 sequences (4.3
kb). Restriction enzyme sites which are indicated are: E,
EcoRI; K, Kpnl.
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Restriction enzyme cleavage analysis of pBH-alpha and
pBH-beta. Based on the nucleotide sequence of the entire
genome of PR-RSV [117] and the env-src EcoRI fragment of SR-RSV
[134], restriction enzymes with cleavage sites in env were
selected for analysis of the BH-RSV genome. Figure 2.2 shows
some of the restriction enzyme cleavage data for pBH-alpha and
pBH-beta.
To orient the DNA fragments which were obtained by digestion with the various restriction enzymes, secondary digestion
with the enzyme Kpnl was performed. The single Kpnl site is
located approximately 200 bases before the stop codon of pol in
PR-RSV, essentially dividing the genome into a gag-pol half and
an env-src half. Kpnl digestion of the 5 kb pol-src EcoRI
fragment of BH-RSV yielded two fragments of approximately 2.7
and 2.4 kb which represent the left and right halves, respectively, of the 5 kb fragment (lane K, see also Figs. 1.1 and
1.2).
The order and identity of the restriction fragments shown
in the gels in Fig. 2.2 was determined by comparison of single
and double digests, comparison of the sizes of the BH-RSV fragments to those of SR- and PR-RSV, and hybridization of a Southern blot of the gel with src specific probe (not shown).

Figure 2^-2^. Restriction enzyme cleavage analysis of pBH-alpha
and pBH-beta. The 5 kb EcoRI viral insert fragments were digested with enzymes as described below and subjected to electrophoresis through 1.5% agarose in a "mini gel" apparatus. Gels
were stained with ethidium bromide. In lanes marked mw, the
first lane was a Hindlll digest of lambda DNA and the second
lane was a HinfI digest of pBR322 DNA. The markings on the
left indicate the positions of the 4.3, 2.0, 1.6, and 0.5 kb
markers. K, Kpnl digest of pBH-beta insert. Lanes marked with
names of enzymes: in each set of 4 lanes, the first and third
lanes were pBH-alpha insert DNAs and the second and fourth
lanes were pBH-beta insert DNAs. The first and second lanes
were single digests with the indicated enzyme and the third and
fourth lanes were double digests with the indicated enzyme and
Kpnl. The faint band at 4.3 kb in many lanes was pBR322 DNA.
Enzymes used were AccI, Ncol, and Nael (upper left); Ball,
PvuII, and BamHI (lower left); and Bgll and Xhol (right).

mw, Bgl , Xho , K

mw

Bal . Pvu , Bam , K
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The individual restriction enzyme fragments which were
cleaved by secondary digestion with Kpnl were identified as
fragments which span the pol-src junction. BH-RSV fragments
which were contained wholly in pol or src were found to be the
same size as the corresponding fragments of SR- or PR-RSV, with
the exception of: 1) An Xhol site, not found in PR- or SR-RSV,
was present in the pol gene of BH-RSV, approximately 800 bp
from the 5' end of the 5 kb insert of pBH-alpha and pBH-beta
(note the 800 bp band in Xhol digests shown in Figure 2.2) 2) A
PvuII site in pol, present in PR-RSV, was not found in either
pBH-alpha or pBH-beta. 3) A second BamHI site, mapping near
the 3* end of the PR-RSV pol gene, was not present in pBH-alpha
or pBH-beta. This site is also not present in SR-RSV [26].
However, an additional BamHI site mapping near the 5' end of
the pol gene was found in pBH-beta. This site was not present
in pBH-alpha (note the different patterns for BamHI digestion
of pBH-alpha and beta), SR-RSV, or PR-RSV.
Except for BamHI digests, restriction fragments of both
pBH-alpha and pBH-beta comigrated indicating that the additional pol defect in BH-RSV alpha was probably not due to a large
deletion or major sequence rearrangement. (The apparent difference between the digestion patterns of pBH-alpha and beta with
the enzyme Nael was not consistently observed and was believed
to be an artifact in this particular reaction).
The results obtained from the restriction enzyme cleavage
analysis are summarized in Figure 2.3. All the restriction enzyme sites which map in pol or src (with the exception of the
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few discussed above) were present in BH-RSV.

All the restric-

tion enzyme sites which map in either env or the intercistronic
region between env and src were absent. The Ncol site, shown
in the figure to map at the border between the intercistronic
region and src, was present in BH-RSV. This cleavage site includes the ATG initiation codon (recognition site for Ncol:
CCATGG) of the PR- and SR-RSV src genes; the presence of the
Ncol site in BH-RSV suggests that the src coding region is intact in BH-RSV.
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Figure 2.3. Restriction enzyme cleavage map of BH-RSV compared
to non-defective RSV. Positions of restriction enzyme cleavage
sites on the RSV genome between the EcoRI site in gag and the
EcoRI site in U^ are indicated. Enzyme sites in pol and gp85
were based on the PR-RSV sequence [117] and sites in gp37
through U~ were based on the SR-RSV sequence [134]. The env
gene was drawn to a larger scale. A (+) or (-) sign below a
position indicates whether the site was present or absent in
BH-RSV; the map refers to both BH-RSV alpha and beta. Dotted
line marking an enzyme site indicates a site which was present
in BH-RSV but not present in PR-RSV. An extra BamHI site which
was present in BH-RSV beta only (see text) is not shown; it
mapped between X and Xb in the 5' portion of pol. Enzymes were
E, EcoRI; Hp, Hpal; Hi, Hindlll; X, Xhol; Xb, Xbal; Ba, BamHI;
Bl, Ball; N, Ncol; P, PvuII; A, AccI; Bg, Bglll; K, Kpnl; B,
Ball.
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Sizing of a pol-src junction fragment.

To further examine

the extent of the missing env sequences in BH-RSV alpha and
beta, the size of the pol-src junction fragment, bounded by the
Kpnl site in pol and the Ncol site at the 5* end of src, was
determined. As shown in Figure 2.4, the Kpnl-Ncol fragment in
BH-RSV was approximately 300 bp. The homologous fragment of
PR- or SR-RSV would be approximately 2.2 kb. If the 3' end of
the BH-RSV pol gene is similar to that of PR-RSV, it would be
expected that following the Kpnl site would be 200 bp of pol,
thus allowing for no more that 100 bp of env or intercistronic
sequences in BH-RSV.
As can be seen in Figure 2.4, the Kpnl-Ncol fragment of
BH-RSV alpha and BH-RSV beta comigrate, suggesting that the pol
defect in BH-RSV alpha is not due to an extension of an env
deletion into the pol gene.

Figure 2^4. Ncol-Kpnl double digests. 5 kb insert of pBHalpha or pBH-beta was digested with Ncol followed by: (left
panel) 5' end-labeling with
P and secondary digestion with
Kpnl, or (right panel) secondary digestion with Kpnl. Electrophoresis was performed on 5% polyacrylamide gels; molecular
weight markers shown in rightmost lane were Hinfl digests of
pBR322 DNA. Panel on left was an autoradiogram, panel on right
was an ethidium bromide-stained gel.
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DNA Sequence Analysis of BH-RSV
Sequence of the pol-src junction in Bryan RSV. The 300 bp
Kpnl- Ncol fragment was partially sequenced by the method of
Maxam and Gilbert [92] according to the strategy depicted in
32
Figure 2.5. The Ncol 5' end was labeled with
P in a kinase
reaction and sequencing in the reverse direction (non-coding
strand) from the initiation codon of src revealed that there
were only 97 bp between the end of pol and the beginning of src
in BH-RSV (Figure 2.5). The 91 nucleotides preceding src in
BH-RSV were found to be essentially identical to the 91 nucleotides preceding src in PR- and SR-RSV, in recombinant rASV 1441
[136], and in c-src [135], the cellular homolog of the viral
src gene. This 91 bp region contains the putative splice acceptor site (SA) for src mRNA, mapped to position -74 relative
to src [117,136].
Immediately preceding this 91 bp region (SA region) in
BH-RSV was the sequence identified as the end of the pol gene,
including the stop codon TAA and 6 nucleotides which follow pol
in PR-RSV. The pol-src junction sequence was confirmed by
sequencing using a Ddel site as the labeled end; partial
sequencing of the 3' end of the BH-RSV pol gene confirmed that
the sequence was essentially identical to that of PR-RSV.
A helper virus-related sequence, which is present between
env and src and repeated between src and the LTR in both SRand PR-RSV, was not present in the region 5' of src in BH-RSV.
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POL-SRC REGION OF BH-RSV
(A)
Compared to end of POL
BH-RSV:
N.D.
)ACATCACCCAAAAGGATGAGGTGA(ND)GAAAGATGAGGYGAGCCCTCTTTTTGCAGGCATTTCCGACTGGATACCCTGGGGAGACGAG
PR-C:
GGTACCCTCTCGAAAAGTTAAACCGG************************CTM***********C**************
Kpn I
Dde I
BH-RSV: CAAGAAGGACTCCAAG(
N.D.
)GAAGACACCCTTGCTGCCAACGAGAGTTAATTATATTGTCTGTATGCTGCAGGAGCTGAGCTGAC
PR-C:
***********»***«GAGAAACCGCTAGCAACAAGCAAGAAAGACCCGGA********»****************************C**AT***TGGTGTCCT*G*CTTG**TG
stop
(B)
pol
Compared to beginning of SRC
splice ace.
PR-C:
BH-RSV:
SR-A:
1441:
c-src:

I

G*AA**AAT*TAG*CT*A***********G*************A**************G*****************^
TGCCAACGAGAGTTAATTATATTGTCTGTATGCTGCAGGAGCTGAGCTGACTCTGCTGATGGCCTCGCGTACCACTGTGGCCAGGCGGTAGCTGGGACGTGCAGCCGACCA
GTGA**TAC*CT**TC*GTAT*************************************G*******^
**GT**TTGTGAAAT*CGC*T********G****************************G*******A*^
TCTG**AG*GA*CTG*CTGTC*******G****************'************G********************************* *************C****CCATGG
-91
start
src
(C)
Nco I
POL-SRC junction in BH-RSV
GAAGACACCTTGCTGCCAACGAGAGTTAATTATATTGTCTGTATGCTGCAGGAGCTGAGCTGACTCTGCTGATGGCCT
-91
stop
src
pol

:D)
lOObp

Figure 2_. _5. DNA sequence of 300 bp Ncol-Kpnl fragment of BHRSV. (A) BH-RSV sequence from Kpnl site to end of pol gene
compared to sequence of homologous region of PR-RSV [117]. (B)
BH-RSV sequence from the end of pol to the Ncol site, compared
to sequence upstream from src in PR-RSV [117], SR-RSV [134],
rASV 1441 [136], and c-src [135]. Termination codon of pol in
BH-RSV is underlined. In (A) and (B), * indicates the same nucleotide as BH-RSV and (N.D.) indicates sequences which were
not determined. (C) Highlight of the pol-src junction in BHRSV. (D) Schematic showing region sequenced and strategy used.
Asterisk with arrow indicates position of pol-src junction as
determined by DNA sequencing. Enzymes: K, Kpnl; D, DdeI; H,
Hpal; N, Ncol.
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—'

end

of Bryan RSV.

Preliminary restriction enzyme map-

ping analysis indicated that the last 500 bp of pBH-beta were
similar to the corresponding region of SR-RSV except for a
short region immediately following the src gene. In this region, BH-RSV did not contain the restriction enzyme cleavage
sites present in the corresponding region of SR-RSV (Figure
2.6). Hybridization experiments indicated that neither the sequence termed "F3" (found on the 3* end of SR-RSV) nor "F2"
(found on the 3* end in PR-RSV) [135] were present in BH-RSV
(data not shown).
The 3' end of the BH-RSV beta, from the last 70 bp of src
to the EcoRI site in the U , , . .
_ region, was sequenced according to
the strategy depicted in Figure 2.6. The results (Figure 2.7)
show an overall similarity between the BH-RSV sequence and the
corresponding SR-RSV sequence, with one major exception. Immediately following the stop codon of src, the next 118 nucleotides of BH-RSV and SR-RSV were completely different. Except
for a few single base changes, and a 12 bp repeat present in
BH- and not in SR-RSV, the remainder of the sequence was the
same in both strains.
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SR-RSV
lOObp

SRC
I I II I I I
M R |A D I A
D
P I Hh

u
JN
Hf Hh R
HI

Hf

BH-RSV
SRC
M R |4
D PH

u
Hf
Hf

Region of
Divergence

-><r

Figure 2.6.
Comparison of the 3' end of BH-RSV and SR-RSV.
Positions of restriction enzyme cleavage sites in the region
between the end of src and the U^ region are shown. SR-RSV
sites are based on DNA sequence in ref. 134. BH-RSV sites
based on restriction mapping analysis of pBH-beta.
Strategy
for sequencing this region of BH-RSV is shown at the bottom of
the figure. Enzymes: M, Mstll; D, Ddel; R, Rsal; PII, PvuII;
A, Alul; Hh, Hhal; Hf, Hinfl; HII, Haell; N, Nrul; S, Sau3A; P,
Pvul; E, EcoRI.
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BH-RSV:
SR-RSV:

GluArgProThrPheGluTyrLeuGlnAlaGlnLeuLeuProAlaCysValLeuLysValAlaGlu###
GGAGCGGCCCACTTTTGAGTACCTGCAGGCCCAGCTGCTTCCTGCTTGTGTGTTGAAGGTCGCTGAATAG
*******************************************************G**********G***
Glu

BH-RSV: TAAACTTGTTGGCACAGCATAGAGTATCTTCTGTAGCTCTGATGACTGCTAGAATAATGCTACGGATAAT
SR-RSV: *GCG*GA*CAAAATTTAAGCTACAACAAGG*AAGGCT*GGCCGACAATTGCATGA*GAATCTGCTTAGGG
[ Fl-A ][ Fl-B
BH-RSV: GTGGGGAGGGCAAGGCTTGCGAATCGGGTTGTAACGGGCAAGGCTTGACTGAGGGGACAATAGCATGTTT
SR-RSV: T*A**CGCTTTGC*CTGCTTCGCGAT*TAC*GCCA*ATAT*C**G*AT**********T*GG*TG*****
Fl-B ][ Fl-C ][ Fl-D
BH-RSV: AGGCGAAAAGCGGGGCTTCGGTTGTACGCGGTTAGGAGTCCCCCCTCAGGATATAGTAGTTTCGCTTTTG
SR-RSV: **********************************************************************
][ PPT ][ U3 begins
BH-RSV: CATAGGGAGGGGGAAATGTAGTCTTATGCAATACTCTTGTAGTGTTGCAACATGCTTATGTAACGATGAG
SR-RSV: ********
p^**********************************Q**************************

BH-RSV: TTAGCAACATGCCTTATATGGAGAGAAAAAGCACTGTGCACGCCGATTGGTGGAAGTAAGGTGGTATGAT
SR-RSV: *************** Q* *********** *****Q*****^******************
****** *Q** *
EcoRI
BH-RSV: CGGTGGTATGATCGTGCCTTATTAGGAAGGCAACAGACGGGTCTGACACGGATTGGACGAACCACTGAATT
SR-RSV: *
******************************* ****^** ******* p^******Q*****

Figure 2.]_. DNA sequence of the 3 ' end of BH-RSV compared to
homologous region of SR-RSV. Amino acids shown represent carboxy terminal residues of src. ###, termination codon of src.
F1A-F1D, see text for explanation. PPT, polypurine tract. *,
same nucleotide as BH-RSV. Blank space indicates nucleotide
not present in SR-RSV.
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Conservation of a helper virus-related sequence in avian
retroviruses.

One copy of "Fl", the sequence present as a

direct repeat on either side of src in SR- and PR-RSV
[117,134], was found on the 3* side of src in BH-RSV (Fig.
2.7).

Comparison of the two copies of Fl in SR- and PR-RSV in-

dicated that the sequence seemed to be composed of discrete
blocks of conserved sequences which I termed Fl A-D.
Since the Fl sequence is also present between env and U~
in RAV-0 [59], Fl is believed to be of helper virus origin.
Examination of the DNA sequence of several avian retroviruses
revealed the remarkable fact that the Fl sequence is present
immediately upstream from U

•

*•

-^ • v. . t.

j.nuu^^j.cn-cxjr u^oi_j.com ±x.wm w i n every virus for which the sequence in this region is known [77,78,110,117,120,134]. Figure

2.8 shows the Fl sequence present in RAV-O, PR-RSV, SR-RSV,
AMV, FSV, Y73 and BH-RSV.

In addition, Fl is also present in

evl, ev2, and RAV-2 [A.M. Skalka, et al personal communication].

Fl is not present in murine retroviruses [123].

Figure 2.8. Comparison of the Fl sequence of RAV-0 with that
of several avian transforming retroviruses. RAVO: RAV-O; sequence shown is 3* end of env through U 3 [59]. Z, sequence
between the termination codon of env and start of Fl in RAV-O.
Other regions are the same as described in legend to Figs. 2.7
and 2.8. 5'SR and 5'PR: 5* side of src in SR- and PR-RSV
respectively. Sequence shown is the 3' end of env through the
env-src intercistronic region [117,134]. 3'BH, 3'SR, and 3'PR:
3' side of src in BH-, SR-, and PR-RSV respectively. Sequence
shown is downstream of src through U-. [Fig. 2.7 and 117,134].
In AMV, Y73, and FSV the sequence shown is downstream of the
one sequence through U- [77,78,110, 120]. *, same nucleotide
as RAV-O; blank space indicates a nucleotide which was not
present. Inserted nucleotides are indicated.

RAV>

enw

/

3

C

z

DC

FI-A

RAVO: AGGCAGCCCGAAAATGGAGCAGTGTAAAGCAGTACATGGGTGGTGGTATGAAACTTGCGAATCGGGCTGTA

5 'SR: G*******T****GCA**AT***A***G*********************AGCG****T**G*****T****
5'PR: ***A**ATGC*GGGC********C**G*** TCA**TA**AT**T*C****************
AMV: ***A**ATGC*CGGC********C**G*** •pCAATTA**AT**T** ****************

3'BH: GTAGCT*TGATG*C**CTAG*ATAATGCTAC*G*T*AT*TG**GA*GGCA*GG*************T****
3'SR: *A*GCTTGGCCG*CAATT***TGAAG**T*T*CTT*G**T*A*GC*CT*TGCG**GCTTCGCGAT*TACGG
3'PR: TCAA*TAAT*CTTC**T**A*A*TGTTTAGCA*TAGGC*TCCTGC**TGCTCCGCGAT*T*CG**T*A*GT

Y73: TT*GCTGTA*C*T*CA*TATCTCCGC**CTTCG*TGACT*CTAG*AA*****G*****************C
FSV: CT**T**GAA*T**AA*TCGGC*C*GCG*A*A*TTGACT*A*A*TAGGCTTTTGCGCT*TT***C*A****

3C
Fl-B
RAVO: ACGGGGCAAGGCTTGACTGAGGGGACTACAGTATGTATAGGCGAAAGGCGGGGCTTCGGTTGTACGCGGTT

5'SR: ********T*****A***A*********TG*C***********J**** ***** **j*** *ACG**AC **
5 'PR: *************** **c* ******** *T* AC** ************ A** *** *TC* ****** **J*** *C**
AMV: *****************c**********T*AC**************A******TC*********l****C**

3 'BH: *****CA*G*CA**************A*T**C****T*********A************************
3 ' SR: CCA*ATAT*C**G*AT************GG**G***T*********A************************
3'PR: *TAAT*TGCA*T**************C*TGA*G**********TC*A**********************A*

Y73:

*****^********************C*T**C**************A************************

PSV: *****T**G*I |***********c*TG*************CT**************************

AGTGAGTAGTATA

][ Fl-C
][ Fl-D
][ PPT
][
U3 begins
RAVO: AGGAGTCCCCTCAGGATATAGTAGTTGCGCTCTTGCATAGAGAGGGGGAAATGTAGTCAAATAGAGCCAGA

5'SR: ***********T************ACA****T*******TGTTACATA*CT*CCCTGTTTTGCCCTTAGAC
5 «pR: ****J********GA*G***G*C**A*AT************G*G* AAA**********TT*ATATTGTCTG
AMV: ****.* *******GA*G***Q*c**A*Afr***ip********G*****************T***c*TAGGTT*

3 'BH: ************************ ***T** * *T** ***** *G **************** *TT**GC*ATACTC
3 'SR: **********J****************T****T********G**A**************TT**GC*ATACTC
CC
,
,
3 'PR: ****A***********|*** *AT*GC*|****T********G*****************TT**GC*ATACTC
iAATTCTGCTTGG;
Y73•

TCTTCCC...AAAT/
*****************G*************T********G*****************TT**GC*ATACTC

FSV" ***G************AG*****AA******T*C******G********G****T*C**GT***TCATCAT
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Comparison of the sequences flanking src in various RSVs.
Figure 2.9 summarizes the relationship between the flanking regions of BH-RSV and those of two other RSVs and a helper virus.
In contrast to the other RSVs, BH-RSV does not have any flanking sequences 5' of the src gene. The 91 bp SA region is
directly linked to the end of pol. On the 3' side of src, BHRSV has one complete copy of the RAV-O Fl sequence. The first
copy of the SR- and PR-RSV Fl sequence (on the 5' side of src)
seems to be complete; however the second copy of Fl (on the 3'
side of src) in these sarcoma viruses lacks the Fl-A region.
In PR-, SR-, and BH-RSV, the ~120 nucleotides immediately following src are unrelated and seem to be unique to the individual strains.
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DISCUSSION
Env Deletion in BH-RSV.
On the basis of DNA sequence data (Fig. 2.5), I estimate
the deletion in BH-RSV to be approximately 1.9 kb. The exact
number of nucleotides which are deleted can not be determined
because of the variation in the size of this region in different non-defective RSVs (Fig. 2.9). The sequence data are in
good agreement with previous size estimates based on restriction enzyme mapping analysis (i.e., 2 kb) [118]; however the
deletion is slightly more extensive than the estimate reported
on the basis of oligonucleotide fingerprinting analysis (i.e.,
1.5 kb) [30].
Sequencing revealed the gp85 and gp37 coding sequences to
be completely absent from BH-RSV. Only the portion of the env
signal sequence which overlaps with the 3* end of pol (in
another reading frame) [see 117] as well as 6 bp which follow
the pol terminator were present in BH-RSV. Since the putative
splice acceptor site for env mRNA maps within the 3' end of
pol, BH-RSV may, in fact, synthesize 2 species of 21S srccontaining mRNA which differ by ~135 nucleotides. (The larger
mRNA species would not be expected to direct the synthesis of a
src-related protein since it would be translated in a different
reading frame than src; this reading frame is also interupted
by several termination codons in the pol-src junction). In addition to the absence of env, the Fl sequence or other flanking
sequences were not present upstream from src. The region
between pol and src in BH-RSV, therefore, does not share any
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homology with ALV and this may explain the inability of BH-RSV
to recombine with ALV to generate a non-defective RSV [70].
The sequence surrounding the pol-src junction of BH-RSV
was examined for sequence information which may shed light on
the mechanism of such a deletion. src gene deletions occur
with high frequency in RSVs resulting in the formation of tdRSV
mutants [70] and examination of the DNA sequence surrounding
the src gene suggests a mechanism for this deletion. In both
PR- and SR-RSV strains, the Fl sequence is repeated on the 5'
and 3' sides of the src gene [17,134]; homologous recombination
between the two Fl's would result in loss of all sequences in
between, including src. Uniformity in the size of many independently derived td isolates [31] as well as DNA sequence
data [151] supports this hypothesis. (However, partial tds
with smaller src deletions [73] were most probably generated by
other mechanisms.)
Examination of the sequence surrounding the pol-src junction in BH-RSV and comparison to other available sequence data,
did not reveal any obvious sequence homologies which would support the notion that a deletion occurred by homologous recombination. In PR-RSV the sequence immediately following pol (TTATATTCTC) shares 8 out of 10 bp with a sequence upstream from
src (TAATATTGTC, -97 to -88 relative to PR-RSV src). A homologous recombination occurring within the 5 bp homology (ATATT)
in these two regions would generate a the sequence of the polsrc junction. However, it is unlikely that such a short homology, 5 bp within an otherwise non-homologous sequence, could
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account for the BH-RSV deletion.

This would be equivalent to

proposing that restriction fragments could be deleted by "homologous recombination" between cleavage sites, a phenomenon that
has not been reported to occur.
Although the DNA sequence of the pol and env genes of SRRSV is not available, comparison of the sequence at the end of
PR-RSV pol with the sequence upstream from SR-RSV src revealed
only a 2 bp homology with the BH-RSV pol-src junction. Therefore, on the basis of sequence data available at the present
time, it appears unlikely that the BH-RSV gene structure is a
result of deletion by homologous recombination. However, because of the limited amount of available DNA sequence data on
pol and env, we are still unable to rule out this possibility.
One approach to determine whether there is a feature inherent in the sequence which renders the env region susceptible
to complete deletion would be to examine the pol-src junction
of other deletion mutants. SR-NY8 is an env-deletion mutant
derived from SR-RSV [71]. Studies are currently in progress to
determine the extent of the deletion in this strain. An identical or similar pol-src junction would suggest a common mechanism of deletion.
The 3' End of BH-RSV.
The sequence of the 3' end of BH-RSV failed to demonstrate
a relationship between BH-RSV and either of the two nondefective viruses, PR- or SR-RSV (Figs 2.7 and 2.9). Although
this may suggest that BH-RSV did not derive from either of
these strains by deletion of env, these sequence data are in-
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sufficient to conclude that BH-RSV is an independently derived
defective sarcoma virus. Too few viruses have been sequenced
thus far and general conclusions about the origins of the various strains cannot be drawn at this time.
Retroviruses have been observed to undergo recombination
at a very high rate when mixtures of viruses are passaged or
when virus is passaged through cells containing endogenous
viral information [48,70]. Because the passage history of the
RSV strains involved several decades of in vivo passage, it is
very important to examine the sequences of endogenous proviruses and several helper viruses. Portions of the RSV genome
which were not subjected to selective pressure may have been
derived from endogenous or helper viruses by recombination. In
fact, it has come to our attention that the BH-RSV sequence
between src and the EcoRI site in U- is also found in RAV-2
[Bizub and Skalka, personal communication]. It is very interesting to note that RAV-2 was originally isolated as a
helper virus in BH-RSV stocks [41]. The differences in the
non-coding regions of BH-, PR-, and SR-RSV may therefore reflect the nature of passenger helper viruses more than the origins of the transforming viruses.
Conservation of a 91_ b£ Region Preceding src.
Takeya and Hanafusa reported that the sequence of the csrc exons is highly conserved in the v-src genes of SR-RSV and
rASV 1441, and that the sequence conservation includes 91 bp of
non-coding information immediately preceding c-src [134,135].
It was therefore proposed that position -91 relative to the
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start of c-src represents the site at which recombination occurred between a helper virus and the c-src gene to generate
the the transforming virus, RSV. Additionally, it was suggested that this same position was involved in the recombination
events which resulted in the generation of rASV by recombination between tdRSV and c-src [134]. Remarkably, the pol-src
junction in BH-RSV occurs at the very same position, -91 relative to src (Fig. 2.5). Examination of the sequence data reveals that BH-, PR-, and SR-RSV have essentially the same nucleotide sequence from position 0 to -91 relative to src;
upstream from this point the three RSVs diverge from each other
and from c-src.
Some implications of this finding include: 1) Conservation
of this sequence would suggest a functional requirement for
this entire region. Position -91 is approximately 12 bp
upstream from a splice acceptor "consensus sequence" [83] which
has been proposed to be the acceptor site for src mRNA
[117,136]. Deletions extending into the consensus sequence and
beyond may impair the the virus' ability to synthesize a functional src gene product. 2) If BH-RSV is an independent defective sarcoma virus, it would appear that the identical site in
c-src could participate in recombination events with helper
virus at (at least) two different sites on the helper virus
genome.
In either case, it is not clear what structural feature or
other property is inherent in the DNA sequence in the vicinity
of -91 to make it such a "hot spot" for recombination and/or
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deletion.
Conservation of the "Fl" Sequence.
The striking conservation of this ~125 bp non-coding sequence in so many avian retroviruses would suggest a functional
role for this sequence. Mutants of tdRSV with deletions in Fl
have been constructed in vitro and deletion of most of Fl (only
Fl-D and part of Fl-C remained) did not affect viral replication [123]. However, a deletion of the entire Fl extending
into the polypurine tract abolished replication. These results
support a functional role for either the polypurine tract or
the last 15 bp of Fl; the role of the bulk of Fl is at present
unclear.
Undoubtedly, the presence of Fl in so many viruses facilitated recombination between various avian retroviruses.
Viruses which were passaged together may have freely exchanged
Fls and neighboring regions. Preliminary evidence [Bizub and
Skalka, personal communication] suggests that such recombination occurred between BH-RSV and its helper virus, RAV-2. Examination of the Fl sequences in Fig. 2.8 reveals the fact that
the Fl sequences of AMV and PR-RSV (between env and src) are
remarkably similar, suggesting they may have once been passaged
with a common helper virus.
RAV-60s are recombinant ALVs which contain an env gene acquired (in whole or in part) by recombination with endogenous
viral sequences [48,52]; the U~ region, however, is derived
from the exogenous virus [23]. BH-RSV does not contain any sequences which are homologous to env but can give rise to RAV-

-79-

60s which have the src gene replaced by subgroup E env [48].
Generation BH-RSV-derived RAV-60s by recombination between BHRSV and an ev provirus would, therefore, most likely involve
crossing-over at homologous sites in the Fl sequence of BH-RSV
and ev genomes. Another cross-over point in a homologous region upstream from env (most likely in pol) would also be required.

-80-

Chapter 3
The pol defect of BH-RSV alpha

INTRODUCTION
The pol gene is probably the most poorly understood of the
retroviral genes. Its mRNA transcript has yet to be isolated
(see introductory chapter), the processing pathway of the gagpol precursor has not been directly shown, and the relationship
between processing and virion assembly remains unclear. A
number of functions have been attributed to the pol gene product: several enzymatic activities [115,142], roles in selection and packaging of cellular tRNAs [102,104,113], and a
suspected role in integration of viral DNA. Unanswered questions still remain regarding the mechanism of reverse transcription of retroviral RNA; the exact role of the p32 endonuclease in viral replication as well as mechanisms for the other
pol gene functions are as yet unknown.
Historically, mutants have been used extensively to study
retroviral gene function. Many pol mutants have been isolated
and have been at least partially characterized [for a review,
see 84]. Since molecular cloning and rapid DNA sequencing
techniques enable investigators to determine the nature of the
defects more precisely, re-examination of pol mutants should
result in new insights in understanding the function of the pol
gene product.
In this study, I present characterization of the pol defect in BH-RSV alpha, a mutant with a stable pol" phenotype.
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The results indicate that the defect appears to affect processing and/or packaging of the pol gene product. This mutant
should therefore prove useful in further studies of these two
pathways.
Transfection of viral DNA proved to be an invaluable assay
for mapping the lesion. Since the original observation that
viral DNA is transforming [55], the transfection assay has been
used extensively to study retrovirus genetics and transformation. In this study, the requirement of viral replication for
transformation of transfected CEF [22] was exploited to develop
a bioassay for pol gene function. In vitro recombination techniques similar to those described in recent reports [98,116],
were used to succesfully localize the pol defect to a discrete
fragment within the pol gene.
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RESULTS
BH-RSV alpha-Infected Cells: Protein Studies
Antiserum controls. The BH-RSV alpha pol-related proteins
synthesized either in the infected cells or packaged into
virion particles were examined by immunoprecipitation followed
by polyacrylamide gel electrophoresis. Antisera directed
against whole virions or specific for reverse transcriptase
were used; the characteristics of these antisera were determined by immunoprecipitation of proteins from RAV-2 virions and
RAV-2-infected cultures. As shown in Fig. 3.1, panel A (lanes
2-3), reverse transcriptase antiserum (anti-pol serum) precipitated the reverse transcriptase subunits, p95p and p63p ,
from virion particles. The serum also precipitated some viral
structural proteins but most of this activity was removed by
absorption of the serum with disrupted virus (compare lanes 2
and 3 ).
The anti-pol serum precipitated the gag-pol precursor
Prl80 from infected cells (lanes 5 and 6); p95P° and p63P°
were not detected in infected cells. The 67K protein which was
precipitated with the absorbed anti-pol serum was a cellular
contaminant as demonstrated in panel B.
Antiserum against whole virions (anti-virion serum) precipitated the gag-pol precursor Prl80 from infected cells (lane
4); the other viral proteins, gPr92env, Pr76gag, p27gag,
pl9gag, pl5/pl2g
well.

g

were precipitated with this antiserum as

Figure 3.1^. Characteristics of anti-pol and anti-virion sera.
(A) Lanes 1 through 3 contain equal amounts of
S-methionine
labeled RAV-2 virions which were purified as described in Materials and Methods. .Lanes 4 through 6 contain immunoprecipitates of lysates of
S-methionine labeled RAV-2 infected
cells. Lane 1, no immunoprecipitation; lanes 2 and 5, immunoprecipitation with anti-pol serum; lanes 3 and 6, immunoprecipitation with absorbed anti-pol serum; lane 4, immunoprecipi
tation with anti-virion serum. (B) Uninfected (CEF) or RAV-2infected (RAV-2) cells were labeled with
S-methionine and
cell lysates were prepared. Immunoprecipitation was performed
with anti-virion serum (V) or anti-pol serum (P). Bands
correpsonding to viral proteins are indentified on the right.
Electrophoresis was performed on 7.5% SDS-polyacrylamide gels.
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Viral proteins in BH-RSV alpha-infected cells.

"Non-

Producer" (NP) clones of CEF infected with BH-RSV alpha, free
of helper virus, were isolated and the viral proteins were examined. Figure 3.2 shows the results of immunoprecipitation of
viral proteins from extracts of BH-RSV alpha-infected cells using the anti-virion or anti-pol antiserum. Immunoprecipitates
from RAV-2-infected cells run in parallel lanes are shown as
controls. In all four NP clones, a band which co-migrates with
the RAV-2 Prl80 was precipitated by both anti-virion and antipol serum. These results clearly indicate that BH-RSV alpha,
although defective in polymerase, can direct the synthesis of a
normal-sized gag-pol polyprotein precursor.
Immunoprecipitation with anti-virion serum (lanes marked
"V") demonstrated the presence of the gag protein products in
BH-RSV alpha-infected cells. As expected from the defectiveness of BH-RSV alpha in env, the env protein gPr92 was not
detectable in the cell extracts from all the NP clones.

Figure 2^-2' BH-RSV alpha proteins in infected cells. Cell
lysates were prepared from cultures which had been labled with
S-methionine. R-2, RAV-2 infected mass culture; 1 through 4,
independent BH-RSV alpha NP clones. Immunoprecipitation was
performed with either anti-virion serum (V) or absorbed antipol serum (P). The positions of molecular weight markers run
in parallel lanes of the gels are shown in the center. The
bands corresponding to Pr76 and Prl80 are identified. Electrophoresis was performed on 5-15% SDS-polyacrylamide gradient
gels.
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Proteins in BH-RSV alpha virions As shown in Fig. 3.1, the
mature reverse transcriptase subunits were not detected in immunoprecipitates of RAV-2-infeeted cells; however p95 and p63
were readily detectable in immunoprecipitates of purified RAV-2
virion particles. Figure 3.3 shows the results of immunoprecipitation of BH-RSV alpha virion particles. No polymeraserelated proteins were detected in the virions released from at
least 3 NP clones (panel A). In each of these 3 clones there
was sufficient production of viral particles, as evidenced by
the precipitation of gag proteins upon reprecipitatation with
anti-virion serum (panel B), to rule out lack of virus production as the cause of the negative result. This confirms earlier results [44,101] in which a radioimmunoassay failed to
detect any pol related products in BH-RSV alpha virions.
In conclusion, the pol-negative mutant, BH-RSV alpha,
directs the synthesis of a full sized Prl80 gag-pol precursor
molecule. However, this molecule is apparently not cleaved
into the mature products p95 and p63 since BH-RSV alpha virion
particles do not contain any polymerase-related proteins.

Figureg3.3 BH-RSV alpha proteins in purified virions. Purified
S-methionine labeled virion particles were immunoprecipitated with absorbed anti-pol serum (panel A). The material
which did not precipitate was reprecipitated with anti-virion
serum (panel B). The lane headings are the same as in Fig.
3.2. The positions of molecular weight markers run in parallel
lanes of the gels are shown in the center. The bands
corresponding to reverse transcriptase are identified. Electrophoresis was performed on 10% (panel A) or 5-15% (panel B)
SDS-polyacrylamide gels.
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Processing of Prl80.

The processing pathway in the pro-

duction of p95 and p63 from Prl80 is not well understood. Cultures of RAV-2-infeeted cells were used to determine whether
processing of Prl80 occurs within virion particles. Cultures
35
were labeled with
S-methionine for a short period, followed
by a "chase" with unlabeled medium, according to the protocol
described by Oppermann [100]. Culture fluid was harvested and
35
S-labeled virion particles were purified, immunoprecipitated
with anti-pol serum, and examined by SDS polyacryalmide gel
electrophoresis. The results (Figure 3.4) show that at early
time points, (30-60 min. of chase), Prl80g

g

™ was the major

£ol-related protein in virion particles. Within the second
hour of the chase, the precursor form, Prl80, was processed
into the mature form, p95 and p63. After 3 hours of chase, p95
and p63 were the major pol-related products in the virions.
These data support the hypothesis that processing of Prl80 occurs exclusively in the virion particles; a similar hypothesis
has been proposed for the processing of the gag-pol precursor
of murine retroviruses [149].

Figure 2*4^ Appearance of pol-related polypeptides in virions
following pulse-labeling of RAV-2 infected cells. A 65 mm dish
of RAV-2 infected CEF which had been starved of methionine for
one hour was labeled with lmCi of
S-methionine for 30 min.
The medium was withdrawn, cells were washed, and fresh medium
containing an excess of unlabeled methionine was added. The
medium was withdrawn and replaced with fresh medium at the indicated time points. Virus was purified from each portion of
medium and immunoprecipitated with anti-pol serum. (0*), the
virus collected after the labeling period; (15'), the virus
collected between 0-15 min after removal of the label; (30'),
30-60 min.; (2h), 1-2 hr; (3h), 2-3 hr; (6h), 3-6 hr; (12h) 612 hr. Electrophoresis was performed on a 7.5% SDSpolyacrylamide gel.
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However when purified virion particles from culture supernatants were examined from cultures which were continuously labeled for various time periods (1 to 6 hr.), Prl80 was not
detectable in the virion particles (data not shown). Although
the labeling conditions in the two experiments differed and
this may account for the discrepancy (1 mCi was used in the experiment in which Prl80 was detected in the virions and 300 uCi
was used in the experiment in which it was not detected),
further work must be done to elucidate the mechanism of Prl80
processing.
Characterization of BH-RSV alpha on the DNA Level
Since the BH-RSV alpha viral genome directs the synthesis
of an apparently normal Prl80 precursor and since no obvious
defects in the structure of the BH-RSV alpha pol gene were
detected by restriction enzyme mapping, I sought to determine
whether the defect actually mapped in the pol gene. The biological activity of the BH-RSV alpha pol gene was tested in a
transfection assay. As a control, the activity of the BH-RSV
beta pol gene was examined in a similar manner.
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TRANSFECTION ASSAY DESIGN

Sal I digest
Ligote
Sail
'A-D-

gp85|gp37

LTR GAG POL ENV SRC LTR

pSR-REP
Derived

pSR-XD
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Transfect CEF
i
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i

Figure _3»J3» Transfection assay design. pSR-REP and pSR-XD are
derived from pSRA, a pBR322 molecular clone containing the entire genome of SR-RSV [24]. After Sail digestion and ligation
of the fragments of the two clones, the ligated mixture is
transfected onto CEF (see Materials and Methods). One of the
ligation products will be a structure equivalent to an SR-RSV
provirus. Sa, position of Sail sites on the plasmids.
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The transfection assay of CEF as designed by Cross and
Hanafusa [24] was used (Figure 3.5). Two SR-RSV molecular
clones, pSR-REP and pSR-XD, are ligated prior to transfection
to generate an intact SR-RSV proviral genome. pSR-REP contains
the SR-RSV 5* LTR, gag and pol genes, and the gp85-portion of
the env gene; pSR-XD contains the SR-RSV gp37-portion of env,
the src gene, and the 3' LTR. Neither plasmid alone can cause
transformation of CEF since viral replication is required for
stable transformation of transfected CEF [22].
Construction of SR-RSV/BH-RSV chimeras. Because of the
requirement of viral replication for stable transformation, it
was possible to use morphological transformation as a marker
for assaying the biological activity of pol. Construction of
in vitro recombinants between the pSR-REP clone and pBH-alpha
or beta clones resulted in generation of viral DNA which contained all of its genes and regulatory sequences from SR-RSV
except for a pol gene which was derived from BH-RSV alpha or
beta. The strategy for construction of these recombinants is
shown in Figure 3.6. The EcoRI-Kpnl fragment contained the
gag-pol junction and more than 90% of the pol gene (the portion
of the pol gene between the Kpnl site and the termination codon
had already been partially sequenced and was found to be essentially identical in the alpha and beta strains (Fig. 2.5)).

E

Bo

Figure 2*£* Construction of SR-RSV/BH-RSV chimeric clones.
(A) Structure of molecular clones which were used to derive the
chimeric constructions [24, and Chapter 2, this thesis]. (B)
Products of EcoRI and Kpnl digestions described in the text.
(C) Structures of resulting recombinants. The positions of
relevant restriction enzyme cleavage sites are shown. For simplicity, in (C) and in Figs. 3.7 and 3.8, the EcoRI and Kpnl
sites are shown at the 5' and 3* borders of pol. E, EcoRI; K,
Kpnl; Xh, Xhol; Ba, BamHI.
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The EcoRI-Kpnl pol-containing restriction fragment was excised from pBH-alpha or pBH-beta DNA by complete digestion with
Kjonl and EcoRI. The excised fragment was ligated to pSR-REP
DNA which had been linearized by complete digestion with Kpnl
and then had the pol-containing EcoRI-Kpnl fragment removed by
partial digestion with EcoRI. DNA of the in vitro-constructed
pol recombinants was amplified by transformation of E. Coli;
colonies were then screened for plasmids of the desired construction. Since both BH-RSV strains contained an Xhol site in
pol which was not present in SR-RSV, and since BH-RSV beta contained an extra BamHI site in pol which was not present in BHRSV alpha or SR-RSV (Fig. 2.3), these two enzymes were used to
determine the origin of the EcoRI-Kpnl pol fragment in the
recombinants. The resulting recombinants, pSR-pol-alpha and
pSR-pol-beta, had the constructions shown in Fig. 3.6C.
Mapping the defect to the pol coding sequences. DNA from
pSR-REP, or the recombinants pSR-pol-alpha or pSR-pol-beta, was
ligated to pSR-XD DNA and transfected onto chicken embryo fibroblasts as shown schematically in Figure 3.5. Replacement of
the SR-RSV pol gene with the BH-RSV alpha pol gene abolished
focus-forming ability, while replacement of the SR-RSV pol gene
with that of BH-RSV beta did not affect focus-forming ability
(Table I). Therefore, the defect which is responsible for the
lack of acitivity in the transfection assay and presumably, for
the lack of reverse transcriptase enzyme in BH-RSV alpha virion
particles, maps within the EcoRI-Kpnl fragment of BH-RSV alpha.
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T R A N S F E C T I O N

Viral
5' portion

DNA
3' portion

pSR-REP

pSR-XD

ASSAY

RESULT
FOCI
Remarks
Total transformation after 8 days

pSR-pola pSR-XD

No foci after 8 days

pSR-pole pSR-XD

Total transformation after 5 days

pSR-XD

No foci after 8 days

Table I. Transfection of CEF with viral DNAs. In each experiment , 4 ug of each DNA species was used for transfection of
four 65 mm dishes of CEF, according to the protocol outlined in
Fig. 3.5. Cultures were transfered and overlaid with agar as
described in the Materials and Methods and monitored for the
appearance of foci.
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Construction of recombinants within the pol gene.

The

Xbal and Bglll cleavage sites within the EcoRI-Kpnl fragment,
divide the 2.7 kb fragment into three fragments of 1.07, 0.86,
and 0.76 kb. Figure 3.7 shows the strategy used for constructing recombinants which would enable the pol defect to be mapped
to one of these three fragments.
pSR-pol-alpha and pSR-pol-beta were used as parentals.
The DNAs were linearized by complete digestion with the
single-cut enzyme SstI and partial digest conditions were used
to generate Sstl-Xbal or Sstl-Bglll fragments cut in pol (Fig.
3.7B). The Sstl-Xbal and Sstl-Bglll "vector" (larger) and "insert" (smaller) fragments from pSR-pol-alpha and pSR-pol-beta
were each cut from an agarose gel and purified separately. To
remove undigested or nicked circular plasmid (i.e., parental)
DNA which may comigrate with the vector fragments, purified
vector fragments were further digested with Hpal. Hpal cleaves
parental DNA at a single site which maps within the fragment
which is not present in the two vectors (Fig. 2.3).
For both the Sstl-Xbal and Sstl-Bglll digestion products,
the pSR-pol-alpha vector was ligated to the pSR-pol-beta insert
and the pSR-pol-beta vector was ligated to the pSR-pol-alpha
insert, resulting in the construction of the four pol recombinants illustrated in Figure 3.7C. BamHI, which differentiates the BH-RSV alpha- and beta-derived inserts, was used to
verify the constructions.
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POL gene
activity

_

_|_
SstI /Xbal digest
OR
Sst I /Bg III digest

Figure 3.»]7. Construction of recombinants within pol. (A)
Structure of molecular clones which were used to derive the
recombinants. Activity of the pol gene was based on data in
Table I. (B) Products of SstI-Xbal or Sstl-Bglll double digestions described in the text. (c"5 Structures of resulting
recombinants. In (A) and (B) the positions of relevant restriction enzyme sites are shown. Ss, SstI; Xb, Xbal; Bg, Bglll;
E, EcoRI; K, Kpnl.
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Localization of the defect to a defined region of pol
c[ene. The four recombinants shown in Fig. 3.7 were used in the
DNA transfection assay to unambiguously map the pol defect to
either the 1.07 kb EcoRI-Xbal ("P") fragment, the 0.86 kb
Xbal-Bglll ("0") fragment, or the 0.76 kb Bglll-Kpnl ("L")
fragment. The gag-pol junction maps in the "P" region; the
site at which p95P° is cleaved into p63p and p32 is thought
to map in the "0" region. As shown in Figure 3.8, given that
the alpha-derived pol fragment is negative and the beta-derived
fragment is positive in the transfection assay, the four recombinants which were constructed would yield a unique array of
results depending on whether the mutation mapped in "P", "0",
or "L". (Other unique patterns of results which would be expected if more than one mutation existed are not shown in the
figure.)
When the four recombinants were tested in the transfection
assay, successful transformation of CEF correlated with a
beta-derived "0" region only. Conversely, inability to produce
foci on CEF, correlated with an alpha-derived "0" region irrespective of the origin of the "P" or "L" fragments (Fig.
3.8).
Thus, the defect in BH-RSV alpha which results in a Prl80
protein which does not seem to be processed is due to a mutation in the coding sequence of its pol gene. The mutation maps
to an 859 bp Xbal-Bglll fragment in the central portion of the
gene. Sequencing of this region is currently in progress.
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TRANSFECTION OF POL RECOMBINANTS
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Figure 2#§.* Transfection of pol recombinants. The structure
and biological activity of the pol gene of pBH-alpha (upper
left) and pBH-beta (upper right) are shown for reference. The
structure of the pol genes of the four recombinants derived in
Fig. 3.7 and the expected results in a transfection assay, assuming that the pol lesion mapped to one of the three indicated
sections of the pol gene are shown in the table. The actual
results were the average o f the results of transfection of 3
independent molecular clon es having the structure shown, except
the third row which was th e average of the results of two
clones.
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Difference between the pol gene of SR-RSV and Bryan RSV
beta. Both SR-RSV and BH-RSV beta have wild-type pol genes
which would be expected to be equally active in a transfection
assay. It appeared that pSR-pol-beta, the construct in which
the pol gene of SR-RSV was replaced with that of BH-RSV beta,
was more active in the transfection assay than the parental
pSR-REP (Table I). pSR-pol-beta consistently (more than 5 independent experiments) caused rapid and complete transformation
of the cultures in 5 days, while under the same conditions,
cells transfected with pSR-REP did not begin to show discernable foci until day 6, and the plates did not become completely
transformed until (at least) day 7.
This observation was confirmed by the measurement of the
kinetics of production of infectious viral particles by pSRREP- and pSR-pol-beta-transfected cultures. Culture supernatants collected daily, beginning 4 days post-transfection, were
used to determine the titer of infectious viral particles. As
can be seen in Figure 3.9, the pSR-pol-beta-transfected cultures consistently contained 10-100 fold more infectious particles than the pSR-REP cultures; even the maximum titer attained
by the two cultures differed by at least a factor of 10.
Replacement of the 2.7 kb EcoRI-Kpnl pol fragment of SRRSV with that of BH-RSV beta resulted in an enhancement of
viral replication. Many functions have been attributed to the
retrovirus pol gene, and we do not know which function in BHRSV contributes to such a dramatic stimulation of infectous
virus.
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Virus production after transfection with
recombinant and wild type viral D N A
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Figure 3^*9^ Titer of infectious virus in culture fluid of
cells transfected with viral DNA. Sail-cut pSR-REP (filled
circles) or pSR-pol-beta (open circles) DNA was ligated to
pSR-XD DNA and ligated DNA was transfected onto CEF. Beginning
four days after transfection, culture fluid was collected daily
and clarified fluid was used to determine the number of focus
forming units (ffu)/ml. For pSR-REP-transfected cultures, the
titer on day 4 was below detection limits of the assay (100
ffu/ml).
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DISCUSSION
Polymerase Defect in BH-RSV alpha
Restriction enzyme mapping studies using a large number of
enzymes found the structure of the BH-RSV alpha pol gene to be
almost indistinguishable from that of wild type pol genes
(Figs. 2.2 and 2.3). Protein studies indicated that although a
full length gag-pol precursor was synthesized, neither the mature processed pol products nor any other polymerase related
proteins were detected in BH-RSV alpha virions (Figs. 3.2 and
3.3). In this respect, the pol defect in BH-RSV alpha seems to
be quite different than that of other non-conditional pol mutants which have been examined biochemically.
The pol" phenotypes in mutants Q-PH9 and SE52d, and in the
provirus ev3 are due to deletions in the respective pol genes;
all three synthesize a truncated form of Prl80 (P140, P125, and
P120 respectively) in infected cells and, with the exception of
ev3 which does not produce viral particles, they do not produce
reverse transcriptase protein in their viral particles
[33,34,85,90].
There does not appear to be a deletion or major sequence
rearrangement affecting the pol sequences of the ev-1 provirus
[60,125], yet like BH-RSV alpha, ev-1 (under conditions where
it is expressed) virion particles do not contain reverse
transcriptase-related proteins [21]. However, immunoprecipitation of cell lysates showed that ev-1-expressing cells do not
synthesize any intracellular gag-pol product [21]. The cause
of the ev-1 pol defect has not been determined.
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The AMV genome directs the synthesis of a full size
Prl80 *^ protein, yet virion particles contain no reverse
transcriptase-related proteins [32]. Although this seems to be
phenotypically identical to the BH-RSV alpha pol defect, the
cause of the AMV defect is now understood. Recent DNA sequence
data has demonstrated that the pol defect in AMV is due to
insertion of the myb gene into the 3* end of pol (between the
Kpnl site and the termination codon) [78,110]. As a result,
the last 36 amino acids of AMV pol are probably derived from
c-myb [78]. However, DNA sequencing of BH-RSV alpha demonstrated that this portion of the pol gene was not significantly
different than the wild type pol gene (Fig. 2.5).
Other models to explain the BH-RSV alpha pol defect must
therefore be considered:
1) Defect in splicing pol mRNA: The avian gag and pol
gene products are encoded on different reading frames of viral
RNA [117] and a splicing event is presumably required to remove
the gag translation terminator and shift the reading frame.
Suppression of the gag terminator and continued translation in
the gag reading frame has been shown to result in a readthrough protein of 80 kD [147]. A shift to the incorrect reading frame would presumably result in an even smaller readthrough protein [based on 117]. Therefore, the presence of a
full size BH-RSV alpha gag-pol precursor protein, containing
pol antigenic determinants, argues against a defect in the
splicing event. However, a splicing defect may explain the nature of the ev-1 defect (see above) [21].
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2)

Lesion outside of pol:

Consistent with the protein

and restriction mapping data is the hypothesis that the defect
in BH-RSV alpha affects its reverse transcriptase protein but
does not map within pol. A possible candidate for such a defect would be the protease responsible for processing of Prl80.
gag
pl5
protease has been implicated in virus maturation
[29,143,144]. In vitro, pl5 cleaves Prl80 non-specifically
[34,94], however, this does not rule out the possibility of a
role for pl5-mediated processing of Prl80 in vivo. In fact,
pl5 has been shown to cleave p95p° quite specifically into
p63P and a 32 kD protein [94]. Assuming that processing of
Prl80 occurs prior to packaging, BH-RSV may be a processing mutant due to a defective protease (pl5 or another, as yet
unidentified, viral activity involved in processing) or due to
an alteration of a cleavage site(s).
3) Defect in packaging: Preliminary evidence presented
in Fig. 3.3 indicates that unprocessed Prl80 may be the moeity
which is packaged into the virions. In that case, a processing
defect cannot account for the lack of detectable reverse
transcriptase-related proteins in virion particles. Even if
BH-RSV alpha Prl80 was not cleaved or cleaved only partially, I
would have expected to detect the accumulation of uncleaved
Prl80 or one of its processing intermediates in virion particles .
If packaging of Prl80 is indeed a prerequisite for processing, BH-RSV alpha may be a packaging mutant with a lesion
in pol which renders the Prl80 protein unpackageable. Alterna-
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tively, if an interaction between the pol proteins and the
virion core proteins or the viral RNA is required for packaging
of the enzyme, a defect in gag or in a non-coding region of
viral RNA could produce the observed phenotype. Although there
is no evidence that such interactions, are required, it is
known that the pol gene product binds tRNAtrp [102] and seems
to be responsible for selecting a specific cellular tRNA pool
for packaging [104,113],
4) Artifact of molecular cloning: The protein analysis
of BH-RSV alpha was performed on many independent clones of NP
cells (Figs 3.2, 3.3, and data not shown), whereas the restriction mapping was performed on one molecular clone. The possibility that the pBH-alpha clone was not representative of the
BH-RSV alpha genome also had to be considered.
The transfection assay resolved many of these points. The
biological activity of molecularly cloned DNA fragments used in
this study was confirmed. The reverse transcriptase defect in
BH-RSV alpha was localized to a specific fragment within the
BH-RSV alpha pol gene, effectively eliminating the possibility
that the lesion mapped outside of pol or in the gag-pol junction. Until the DNA sequence of the defective region is available, the exact nature of the pol defect is still a matter for
speculation.
The cleavage site used in processing p95 into p63 and p32
is thought to map within the defective region [D. Grandgenett,
personal communication]. While such a defect would certainly
affect processing of reverse transcriptase, whether it could
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also affect packaging of pol products is not clear.

However,

if the defect causes a major alteration in the protein sequence, a conformational change affecting Prl80 (or p95) may
prevent proper packaging.
The pol defect in AMV may also be related to packaging.
It does not seem likely that the proposed carboxy terminal substitution in the AMV Prl80 protein affects any of the cleavage
sites used in processing of this protein. Since pol (or polrelated) proteins are not detected in viral particles, the
resulting alteration in protein structure may prevent proper
packaging. Further studies on the fate of the BH-RSV and AMV
Prl80 proteins should be useful in establishing the relationship between processing and packaging.
Proposed mechanisms for the generation of the BH-RSV alpha
defect must account for both the frequency of its occurance
(5-10%) and its low rate of spontaneous reversion [46]. A
point mutation is unlikely to be stable. An in-frame deletion
would be consistent with the evidence presented, provided the
deletion was small enough to be undetectable by the restriction
enzyme mapping analysis. Another possibility is that the BHRSV alpha pol defect is generated by recombination. Almost all
the ev proviruses contain some pol sequences [53]. Since earlier studies found the frequency of generation of the BH-RSV
alpha defect to be independent of the gs or chf phenotype of
the embryo [112], a recombination model would have to assume
»

that there is a defective portion of pol which is conserved
among most of the ev's, or would have to assume recombination
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mvolved the commonly found provirus ev-1.

It is possible that

ev-1 contains an internal defect in pol, in addition to the
proposed splicing defect (see above).
Processing of Prl80
Whereas mature reverse transcriptase protein and enzymatic
activity are readily detectable in virion particles, many workers have reported the inability to detect the reverse transcriptase subunits or reverse transcriptase enzymatic activity
in retrovirus-infected cells [34,51,100,149]. It is therefore
believed that cleavage of Prl80 and formation of mature pol
products occurs very close to the time of release of virion
particles from the infected cells. However, whether cleavage
occurs before, after, or during the budding process has not
been resolved. Although there is general agreement regarding
the absence of detectable amounts of p95 and p63 in infected
cells, the presence of Prl80 in mature virion particles is the
subject of conflicting reports.
In the report in which the avian Prl80g

g

^ was initial-

ly described, Oppermann et al [100] note the presence of high
molecular weight bands in polyacrylamide gels containing proteins from purified virion particles and suggest that one of
these bands represents Prl80. This high molecular weight protein comigrates (on their gel system, i.e., 11% polyacrylamide)
with Prl80 found in infected cells and appears in pulse-chase
experiments only in virion particles harvested at early time
points after removal of the radioisotope. However immune precipitation was not used to firmly establish the identity of
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this band as the pol precursor.
Moelling et al [94] report the presence of Prl80 in
Coomassie blue-stained polyacrylamide gels of disrupted virion
particles. Virion "Prl80" was identified by comigration with
cellular Prl80; immune precipitation was not used.
Eisenman et al [34] report the absence of Prl80 in radioactively labeled virion particles which were immunoprecipitated with anti-reverse transcriptase serum. Virions were
purified from cultures which had been labeled continuously for
1-6 hr. These workers also report (although the data is not
shown) that Prl80 could not be immunoprecipitated from virions
purified from cultures which they had labeled according to the
pulse-chase protocol described by Oppermann et al.
In an attempt to clarify this conflict, I repeated the experiments of Oppermann et al and Eisenman et al. In order to
verify the identity of high molecular weight bands which may
appear in the virions, immunoprecipitation with anti-pol serum
was used in repeating Oppermann's experiment. In our experiments in which parallel cultures of infected cells were used,
the contradictory reports of both sets of workers were confirmed; Prl80 was clearly identified in virions in the pulsechase experiment and was undetectable in the continuous labeling experiment (Fig. 3.4, and data not shown). These results
must therefore be regarded as preliminary and resolution of the
question of packaging of Prl80 will require further investigation.
Temperature sensitive packaging mutants Mo-MuLV ts3 [150]
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and Ra-MuLV ts24 [131] were used to study the maturation of murine retroviruses. These studies [149] suggest that the sequence of events in late stages of assembly is: encapsidation
of uncleaved PrlSO9^"^1 followed by cleavage into reverse
transcriptase in newly formed virions. Processing of Prl80 appears to occur rapidly, within 40 min of release of the virion
particle. These workers suggest that activation of reverse
transcriptase in virion particles may reflect a general mechanism whereby premature reverse transcription of viral RNA is
prevented from occurring within the cell. For this reason, activation of reverse transcriptase (by cleavage) within virion
particles would be advantageous to avian retroviruses as well.
Enhanced viral production by the pol gene of BH-RSV beta
It is not clear which function of the BH-RSV beta pol gene
product accounts for the increased production of infectious
virus by cells which were transfected by pSR-pol-beta as compared to pSR-REP (Fig. 3.9). Possibly, the rate of one of the
enzymatic activities of the reverse transcriptase protein is
increased. Alternatively, assuming that packaging of reverse
transcriptase (either as Prl80 or as p95/p63) or selection of
tRNA ^ and/or binding of it to viral RNA are somewhat inefficient processes, the BH-RSV pol gene product may have a structural alteration which increases its efficiency. In such a
model, the ratio of infectious to physical viral particles
would be higher in viruses containing the BH-RSV pol gene.
Further work will have to be done to understand this puzzling phenomenon. The virus harvested from the supernatants of
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pSR-REP and pSR-pol-beta transfected cultures should be examined to determine the kinetics of production of infectious particles early after infection. Also, to rule out the possibility that the pol gene of pSR-REP may have incurred a defect during molecular cloning, SR-RSV virus should be included for comparison in future experiments. It would also be interesting to
examine the purified enzyme encoded by BH-RSV beta pol. If the
efficiency of synthesis or fidelty of the transcript is substantially increased in comparison to other viral polymerases,
this enzyme may be valuable for in vitro uses of reverse transcriptase (i.e., cDNA cloning).
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